abdullah's picture
Add files using upload-large-folder tool
290eb2f verified
raw
history blame
71.7 kB
1
00:00:01,940 --> 00:00:04,480
ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ุตู„ุงุฉ ูˆุงู„ุณู„ุงู… ุนู„ูŠ ุณูŠุฏ
2
00:00:04,480 --> 00:00:10,260
ุงู„ุฎู„ู‚ ุฃุฌู…ุนูŠู† ุณูŠุฏู†ุง ู…ุญู…ุฏ ุงู„ุตุงุฏู‚ ุงู„ุฃู…ูŠู† ูˆุจุนุฏ ู†ู„ุชู‚ูŠ
3
00:00:10,260 --> 00:00:18,980
ุงู„ูŠูˆู… ููŠ ู…ุญุงุถุฑุฉ ุฌุฏูŠุฏุฉ ุจุนู†ูˆุงู† chronic leukemia ูˆ by
4
00:00:18,980 --> 00:00:24,580
definition chronic leukemiaู‡ูŠ ุนุจุงุฑุฉ ุนู† ุจู„ูˆูƒูŠู…ูŠุง
5
00:00:24,580 --> 00:00:28,800
ุจุชุญุฏุซ ููŠู‡ุง mutation ุนู„ู‰ ู…ุณุชูˆู‰ ุงู„ stem cell in a
6
00:00:28,800 --> 00:00:32,560
single stem cell mutation ุญุตู„ุช in a single stem
7
00:00:32,560 --> 00:00:37,060
cell ูˆ ู‚ุฏ ุชูƒูˆู† ู‡ุฐู‡ ุงู„ stem cell ูู‰ ุงู„ุจุถู…ุฑุฉ ุงูˆ ุงู„
8
00:00:37,060 --> 00:00:45,680
tissue ุงู†ู…ุง ู…ุง ูŠุชุจุน ุฐู„ูƒ ุงู† ู‡ุฐู‡ ุงู„ุฎุฏูŠุฉ ุชู†ู‚ุณู… ู‚ุณู…ุงุช
9
00:00:45,680 --> 00:00:52,140
ุนุฏูŠุฏุฉ Campyloferin ูˆ ุจุชูƒูˆู† clonal populationุงู„ู„ูŠ
10
00:00:52,140 --> 00:00:58,240
ู„ู…ุง ุจูŠูƒูˆู† ู…ุงุณ ูƒุจูŠุฑุฉ ุจูŠุนู…ู„
11
00:00:58,240 --> 00:01:03,920
ุงู„ู…ุฑุถ ู…ุงููŠ ุฃู†ูˆุงุน ุงู„ chronic leukemia ุงู„ู†ูˆุนูŠู† ุญุณุจ
12
00:01:03,920 --> 00:01:06,860
ุงู„ predominant cell type ุงู„ chronic myeloid
13
00:01:06,860 --> 00:01:10,800
leukemia ูˆ chronic lymphoid leukemia ูˆ ู‡ู†ุจุฏุฃ ุจุงู„
14
00:01:10,800 --> 00:01:14,920
chronic myeloid leukemiaูˆุงู„ู„ูŠ ู‡ูŠ by definition ู‡ูŠ
15
00:01:14,920 --> 00:01:18,460
ุนุจุงุฑุฉ ุนู† stem cell disorder ุฒูŠ ู…ุง ุงุชูู‚ ู†ุทูˆูŠ ุดูˆ
16
00:01:18,460 --> 00:01:21,400
ุจูŠู‚ูˆู„ูˆุง ููŠู‡ุงุŸ ุจูŠู‚ูˆู„ูˆุง ุงู†ู‡ ุชุชู…ูŠุฒ ุจูˆุฌูˆุฏ ููŠ ุงู„ุฏู„ูŠู„
17
00:01:21,400 --> 00:01:27,040
ููŠู‡ chromosome positive ู…ูˆุฌูˆุฏ ููŠ ูƒู„ stem cell ุดูˆ
18
00:01:27,040 --> 00:01:30,280
ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ุงุŸ ู…ุงุฏูŠุงุช ุจุนุฏ ุฐู„ูƒ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ุง
19
00:01:30,280 --> 00:01:33,880
replacement of normal bone marrow stem cell ุฃูˆ
20
00:01:33,880 --> 00:01:40,420
cell with abnormalStem cell that have Philadelphia
21
00:01:40,420 --> 00:01:44,900
chromosome positive ุดูˆู Philadelphia chromosome ู‡ูˆ
22
00:01:44,900 --> 00:01:48,440
ุจุฑุงู…ุฌ Translocation ู…ุง ุจูŠู† ูƒุฑู…ุฒูˆู… ุฑู‚ู… ุชุณุนุฉ ูˆุงุชู†ูŠู†
23
00:01:48,440 --> 00:01:55,600
ูˆุนุดุฑูŠู† ููŠ ุงู„ QR 34 ู…ุน ุงู„ QR 11
24
00:01:57,520 --> 00:02:02,260
ูˆู‡ุฐู‡ ุงู„ู„ูˆูƒูŠู…ูŠุง ุชุชูƒูˆู‘ู† ู…ู† 6 ู†ูˆุนูŠู† ู…ุฎุชู„ูุฉ ูƒุฑูˆู†ูŠูƒ
25
00:02:02,260 --> 00:02:06,440
ู…ุงูŠู„ูˆูŠุฏ ู„ูˆูƒูŠู…ูŠุง ูู„ุงุฏู„ููŠุง positive ูƒุฑูˆู†ูŠูƒ
26
00:02:06,440 --> 00:02:11,140
ุฌุฑุงู†ูŠูˆู„ุงุณุชูŠูƒ ู„ูˆูƒูŠู…ูŠุง ูƒุฑูˆู†ูŠูƒ ู…ุงูŠู„ูˆูŠุฏ ู„ูˆูƒูŠู…ูŠุง
27
00:02:11,140 --> 00:02:16,740
ูู„ุงุฏู„ููŠุง negative ูƒุฑูˆู†ูŠูƒ
28
00:02:16,740 --> 00:02:21,000
ู…ุงูŠู„ูˆูŠุฏ ู„ูˆูƒูŠู…ูŠุง ูƒุฑูˆู†ูŠูƒ ู…ุงูŠู„ูˆูŠุฏ ู„ูˆูƒูŠู…ูŠุงู…ุซู„ู‹ุง ูƒุฑูˆู†ูƒ
29
00:02:21,000 --> 00:02:26,360
ู†ูŠุชุฑูˆููŠู„ูƒ ู„ูˆูƒูŠู…ูŠุง ูˆุงู†ูƒุฑูˆู†ูƒ ุฅูŠุฒูŠู†ูˆููŠู„ูƒ ู„ูˆูƒูŠู…ูŠุง ุซู…
30
00:02:26,360 --> 00:02:32,300
ู†ูˆุน ุงู„ุณุงุฏุณ ูƒุฑูˆู†ูƒ ู…ุงูŠู„ูˆู…ูˆู†ูˆุณูŠุชูƒ ู„ูˆูƒูŠู…ูŠุง ู…ุง ู‡ูŠ
31
00:02:32,300 --> 00:02:35,060
ุงู„ุงู†ุณุฏุงู†ุณ ู„ู‡ุฐุง ุงู„ู…ุฑุถุŸ ูƒุงู„ูƒุฑูˆู†ูƒ ู…ุงูŠู„ูˆู…ูˆู†ูˆุณูŠุชูƒ
32
00:02:35,060 --> 00:02:40,880
ู„ูˆูƒูŠู…ูŠุง ุจุชุดูƒู„ 20% ู…ู† ูƒู„ ุฃู†ูˆุงุน ุงู„ู„ูˆูƒูŠู…ูŠุง ูˆู‡ูŠ ุฃูƒุซุฑ
33
00:02:40,880 --> 00:02:45,960
ู†ุฏุฑุฉ ู…ู† ูƒุฑูˆู†ูƒ ุฑูˆู…ููˆุณูŠุชูƒ ู„ูˆูƒูŠู…ูŠุง ุงู†ุณุฏุงู†ุณ ุฑูŠุช ุชุจุนุชู‡ุง
34
00:02:45,960 --> 00:02:49,500
ูˆุงุญุฏ ู„ุญุงู„ุฉ ู„ุญุงู„ุชูŠู† ุจูƒู„ ู…ุงุฆุฉ ุฃู„ู ู…ู† ุงู„ population
35
00:02:50,640 --> 00:02:55,320
ูˆุงู„ู€ peak incidence ููŠู‡ุง ู‡ูˆ ุงู„ middle age people
36
00:02:55,320 --> 00:03:00,920
ุทุจุนุง ุงู„ male ุฏุงูŠู…ุง ู†ุตูŠุจู‡ู… ุฃูƒุจุฑ ู…ู† ุงู„ female ุงู„
37
00:03:00,920 --> 00:03:05,990
male to female ratio ู‡ูŠ one point four to oneู„ูƒู†
38
00:03:05,990 --> 00:03:09,670
ุงูŠุถุง ู…ู…ูƒู† ุชุดูˆู ู‡ุฐู‡ ููŠ ุงู„ุฃุทูุงู„ ููŠ ุงู„ new-age and
39
00:03:09,670 --> 00:03:14,550
very old people ู…ุด ุดุฑุท ุงู„ middle-aged people ู„ูƒู†
40
00:03:14,550 --> 00:03:19,190
ุจุดูƒู„ ุนุงู… ุงู„ peak incidence ู‡ูˆ ู„ู„ middle-aged
41
00:03:19,190 --> 00:03:22,610
people ุดูˆู Philadelphia chromosome ุทุจุนุง ููŠ
42
00:03:22,610 --> 00:03:26,130
Philadelphia chromosome ุจุชุนุฑููˆุง ุงู†ู‡ ู‡ูˆ ุจูŠุตูŠุฑ ููŠ
43
00:03:26,130 --> 00:03:29,570
translocation ู…ุง ุจูŠู† ูƒุฑู…ุฒูˆู… ุชุณุนุฉ ูˆ ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู†
44
00:03:29,570 --> 00:03:34,750
ู…ุง ุจูŠู† ุงู„ Q arm ู„ู‡ุฐุง ูˆ ุงู„ Q arm ู„ู‡ุฐุงูˆุงู„ู„ูŠ ุจูŠุตูŠุฑ
45
00:03:34,750 --> 00:03:38,670
ุฅู†ู‡ ุจูŠู†ุชู‚ู„ ุฌุฒุก ู…ู† ุงู„ู€ Appelsauce ุจุฑูˆุชูˆ ุฃู…ูƒุฑุฌูŠู†
46
00:03:38,670 --> 00:03:46,290
ู…ุงุดูŠ ุงู„ู„ูŠ ู…ูˆุฌูˆุฏ ููŠ ูƒุฑู…ุฒูˆู… ุฑู‚ู… 9 ุฅู„ู‰ ุงู„ PCR region
47
00:03:46,290 --> 00:03:54,580
ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ูƒุฑู…ุฒูˆู… ุฑู‚ู… 22ูˆ ุฃูŠุถุง ุฌุฒุก ู…ู† ุงู„ PCR
48
00:03:54,580 --> 00:04:01,320
ุชุจุน 22 ุจูŠุฑูˆุญ ุนู„ู‰ ุฑู‚ู… 9 ูˆ ุงู„ู…ุญุตู„ุฉ new chromosome ูˆ
49
00:04:01,320 --> 00:04:04,400
ุงู„ chromosome ุงู„ abnormal ุงู„ chromosome ู‡ูˆ ุจูŠุทู„ุน
50
00:04:04,400 --> 00:04:09,400
22 ุจูŠูƒุจุฑ ูƒุชูŠุฑ ูˆ ุจูŠุณู…ูˆู‡ Philadelphia chromosome
51
00:04:12,750 --> 00:04:20,490
100% ูˆ ุทุจุนุง ู‡ุฐุง ู‡ูˆ ุงู„ุดูƒู„ ู‡ุฐุง ุชุณุน ูˆู‡ุฐุง ู…ุงุดูŠ ู‡ุฐุง ุชุณุน
52
00:04:20,490 --> 00:04:27,690
ูˆู‡ุฐุง ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู† ุงูŠ ุฌุฒุก ุงู„ APL ูˆู‡ูŠ ุฌุฒุก ุงู„ PCR
53
00:04:27,690 --> 00:04:34,590
ู…ุงุดูŠ ุงู„ ุดูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ุงู† ุงู„ APL ุฌุฒุก ู…ู†ู‡ ูŠุฑูˆุญ ุนู„ู‰
54
00:04:34,590 --> 00:04:42,690
ุงู„ PCR region ููŠ ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู†ูˆุทุจุนุง ุฌุฒุก ุงู„ู„ู‰ ู‡ูˆ
55
00:04:42,690 --> 00:04:48,510
ุงู„ู…ุชุจู‚ู‰ ู…ู† 22 ุจุฑูˆุญ ุนุงู„ู…ูŠู† ุนู„ู‰ ูƒุฑู…ุฒูˆู… ุฑู‚ู… 9
56
00:04:48,510 --> 00:04:52,170
ูˆุจุงู„ุชุงู„ูŠ ุจูŠุตูŠุฑ ููŠู‡ ุนู†ุฏู†ุง new abnormal ูƒุฑู…ุฒูˆู… ุงู„ู„ู‰
57
00:04:52,170 --> 00:04:59,890
ู‡ูˆ ุฑู‚ู… 22 ูƒุจูŠุฑ ุทูŠุจ ุงู„ pathogenesis ูŠุนู†ูŠ ุงู„
58
00:04:59,890 --> 00:05:04,310
hemipoietic abnormality ุจุชุงุนุชู‡ ู†ุชูŠุฌุฉ expansion of
59
00:05:04,310 --> 00:05:05,810
granulocytic progenitors
60
00:05:08,190 --> 00:05:12,530
ู…ุงุดูŠ ุจุชุฒูŠุฏ ุนุฏุฏู‡ุง ูˆ ุจูŠุตูŠุฑ ููŠู‡ decrease ู„ู„
61
00:05:12,530 --> 00:05:18,550
sensitivity of progenitor cell to regulation ุจุชุจุทู„
62
00:05:18,550 --> 00:05:22,690
ุชุชุญ .. ูŠุนู†ูŠ ุชุฑุฏ ุนู„ู‰ ุงู„ control .. ุงู„ regulatory
63
00:05:22,690 --> 00:05:27,610
mechanism ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ decrease sensitivity ู„ู„ุฎู„ุงูŠุง
64
00:05:27,610 --> 00:05:33,610
ุงู„ุจุฏุงุฆูŠุฉ to control mechanism ู‡ุฐุง ุจูŠู‚ุถูŠ ุฅู„ู‰ ุฒูŠุงุฏุฉ
65
00:05:33,610 --> 00:05:40,050
ููŠ ุงู„ white cell countู…ูŠุฌุง ูƒุงู„ูŠูˆ ุณุงูŠุชูˆ ุจูŠูˆูŠุณูŠุฒ
66
00:05:40,050 --> 00:05:46,710
ุบุงู„ุจุง ู…ุซู„ุง ู‡ูŠ expansion ู„ุฃู†ู‡ ู…ุณุชู…ุณ ุงู„ูˆุงุญุฏุฉ ุซู…
67
00:05:46,710 --> 00:05:50,970
ุงู„ุงุฑุชุฑูˆ ุจูŠูˆูŠุณูŠุฒ is usually deficient ู„ุฅู†ู‡ ุจูŠุตูŠุฑ
68
00:05:50,970 --> 00:05:57,110
ููŠู‡ ุชูุถูŠู„ ู†ูˆุน ู…ู† ุงู„ุฎู„ุงูŠุง ุนู„ู‰ ุญุณุงุจ ู†ูˆุน ุขุฎุฑ ุซู… ุงู„
69
00:05:57,110 --> 00:06:00,350
function of neutrophil and platelet is nearly
70
00:06:00,350 --> 00:06:05,450
normal ููŠ ุงู„ุจุฏุงูŠุฉ ุทูŠุจ ู…ู† ู†ุงุญูŠุฉ ุงู„ genetic
71
00:06:05,450 --> 00:06:12,360
abnormality ุดูˆ ุงู„ู„ูŠ ุตุงุฑุŸุงู„ู„ูŠ ุตุงุฑ ุงู†ู‡ ุตุงุฑ ููŠู‡
72
00:06:12,360 --> 00:06:17,840
acquire genetic abnormality ู†ุชูŠุฌุฉ ุงู„ translocation
73
00:06:17,840 --> 00:06:24,440
ู…ุง ุจูŠู† ูƒุฑู…ุฒูˆู… ุชุณุนุฉ ูˆ ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู† ูˆ ุญุตู„ ุงู†ู‡ ุตุงุฑ
74
00:06:24,440 --> 00:06:30,790
ููŠู‡ ุชุฌู…ุน ู„ PCR APL regionูˆุนุดุงู† ู†ุนุฑู ุดูˆ ุงู„ู„ูŠ ุตุงุฑ
75
00:06:30,790 --> 00:06:36,570
ู†ุนุฑู ุงู„ function of both PCR ูˆ APL these are
76
00:06:36,570 --> 00:06:43,310
tyrosine phosphokinase enzyme they are
77
00:06:43,310 --> 00:06:50,310
phosphokinase enzyme ู…ุงุดูŠ ูˆู…ุญุตู„ุฉ ู‡ุฐุง ุงู„ุงุฑุชุจุงุท
78
00:06:50,310 --> 00:06:54,850
ุชูƒูˆูŠู† protein ุจุณู…ูˆู‡ protein 210 ุชุญุณุจ ุงู„ู…ู…ู„ูƒุฉ ุงู„ู„ูŠ
79
00:06:54,850 --> 00:06:59,240
ุฑูˆูŠุช ุชุงุจุน 210 ุฏูˆู„ุงุฑูˆู‡ุฐุง ุงู„ุจุฑูˆุชูŠู† ูŠู„ูˆ function
80
00:06:59,240 --> 00:07:07,020
ุฌุฏูŠุฏุฉ ููŠ ุงู„ูˆุถุน ุงู„ุทุจูŠุนูŠ ุงู„ normal APL gene ุจูŠุทู„ุน
81
00:07:07,020 --> 00:07:11,480
ู„ู†ุง ุจุฑูˆุชูŠู† ุงุณู… our encode for ุงู„ุจุฑูˆุชูŠู† ุจูŠุณู…ูˆ ุจูŠ
82
00:07:11,480 --> 00:07:17,300
one four five APL ู…ุฑุฉ ุชุงู†ูŠุฉ ุจุฐูƒุฑ ุงู„ุฃู‚ุงู… ู‡ุฐู‡
83
00:07:17,300 --> 00:07:22,820
denotes for the molecular weight ูŠุจู‚ู‰ ุงู„ APL
84
00:07:22,820 --> 00:07:26,760
ุจูŠุฏูŠู†ุง ุจุฑูˆุชูŠู† one four five APL
85
00:07:29,180 --> 00:07:35,500
ุนุธูŠู…ุชู‡ ุจุดูƒู„ ูƒุงู…ู„ ู…ุด ู…ูู‡ูˆู… ู„ูƒู† ุจูŠู‚ูˆู„ูˆุง ุงู†ู‡ ุจูŠุดุชุบู„
86
00:07:35,500 --> 00:07:41,310
ูƒุชูŠุฑูˆุฒูŠู† ูƒุงูŠู†ูŠุฒ activityุจู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ
87
00:07:41,310 --> 00:07:43,690
ุงู„regulation of several different growth factors
88
00:07:43,690 --> 00:07:48,670
ูˆุจู…ุง ููŠู‡ุง ุงู„ epidermal growth factor ูˆ ุงู„ platelet
89
00:07:48,670 --> 00:07:52,610
growth factor ูˆ ูƒู„ ุงู„ stimulating factor ูŠุจู‚ู‰ ู‡ูˆ
90
00:07:52,610 --> 00:08:00,910
ู…ู† ูŠุชุญูƒู… ุจูŠู‡ ุงู„ growth factor hormone ุงูˆ ุงู„
91
00:08:00,910 --> 00:08:07,090
cytokine ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ููŠู‡ ููŠ ุงู„ hemopoietic organ
92
00:08:12,800 --> 00:08:23,200
ุงู„ PCR ุฌูŠู† ุฌุงู„ู‡ ุงุช ูƒูˆุฏุฒ for a protein ุณู…ูˆู‡ P160
93
00:08:23,200 --> 00:08:29,440
-PCR ูˆุฏู‡ ุนุจุงุฑุฉ ุนู† ุจุฑุถู‡ ูƒุงูŠู†ูŠุฒ ุงู†ุฒุงูŠู… ู‡ูˆ ุนุจุงุฑุฉ ุนู†
94
00:08:29,440 --> 00:08:36,460
serine-threonine ูƒุงูŠู†ูŠุฒ ุงู†ุฒุงูŠู… ูˆุชู‚ุฑูŠุจุง
95
00:08:37,810 --> 00:08:45,830
ูŠุดุจู‡ ูƒุซูŠุฑ ุนุฏุฏ ู…ู† ุงู„ุจุฑูˆุชูŠู†ุงุช ุงู„ู€ Cell Cycle ูŠุนู†ูŠ
96
00:08:45,830 --> 00:08:52,170
Cell Cycling ุจุฑูˆุชูŠู† ูˆูŠูƒูˆู† ู‡ู†ุงูƒ ุนุฏูˆ ูƒุจูŠุฑ ููŠ
97
00:08:52,170 --> 00:08:57,730
Cellular Signal Transduction ูˆุจุงู„ุชุงู„ูŠ ุนู†ุฏู…ุง ุชุชูƒู„ู…
98
00:08:57,730 --> 00:09:05,890
ุนู† PCR-ABL Fusion Gene ู‡ุฐุง ุงู„ูƒู…ุจูŠูˆู†ุฉ ุชุทู„ุน ู„ู†ุง
99
00:09:05,890 --> 00:09:15,270
ุจุฑูˆุชูŠู†ู…ู„ูƒุฉ ุงู„ูˆูŠุช ุชุจุน 210,000 ูˆ ุจูŠุณู…ูˆู‡ P210 PCR APL
100
00:09:15,270 --> 00:09:21,850
ูˆ ุจูŠู‚ูˆู„ ุงู† ุงู„ุจุฑูˆุชูŠู† ู‡ูˆ ูƒุชูŠุฑูˆุฒูŠู†
101
00:09:21,850 --> 00:09:29,360
ูƒูŠู†ูŠุฒ ุงูƒุชุฑ ู…ู† ุงู„ P145 APLู‡ูˆ ุฃูŠุถู‹ุง ูŠุญุชุงุฌ ุฅู„ู‰ ุนู…ู„ูŠุฉ
102
00:09:29,360 --> 00:09:33,160
ุงู„ุชุนุงู…ู„
103
00:09:33,160 --> 00:09:41,960
ู…ุน ู…ุฌู…ูˆุนุชู‡ ุจู‚ูˆุฉ ุฃูƒุจุฑ ุชูู‚ู†ุง ุนู„ู‰ ุฃู† ุงู„ุจุฑูˆุชูŠู† ุงู„ู„ูŠ
104
00:09:41,960 --> 00:09:48,740
ูŠุชูƒูˆู‘ู† ู…ู† ู‡ุฐุง ุงู„ู€ Translocation ู‡ูˆ P210-PCR-ABL
105
00:09:48,740 --> 00:09:53,800
ุงู„ู„ูŠ ูŠุญุชุงุฌ ุฅู„ู‰ ุนู…ู„ูŠุฉ ุงู„ุชุนุงู…ู„ ู…ุน ู…ุฌู…ูˆุนุชู‡ูˆุจุงู„ุชุงู„ูŠ
106
00:09:53,800 --> 00:09:56,040
ุงู†ู‡ุง ุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
107
00:09:56,040 --> 00:09:56,780
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
108
00:09:56,780 --> 00:10:00,680
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
109
00:10:00,680 --> 00:10:01,560
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
110
00:10:01,560 --> 00:10:01,980
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
111
00:10:01,980 --> 00:10:05,280
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
112
00:10:05,280 --> 00:10:11,280
ูˆุงู†ุฒุนุฌ ูˆุงู†ุฒุนุฌ
113
00:10:11,280 --> 00:10:17,320
ูˆุงู†ุฒุชูˆ ุฌูŠู†ูŠ cluster ุจุงู„ู…ู†ุงุณุจุฉ ุจุตุงุฑ ู„ู‡ู… ู…ุด fusion
114
00:10:17,320 --> 00:10:21,840
ูˆุงุญุฏ code for growth factor ูˆ growth factor
115
00:10:21,840 --> 00:10:27,400
receptor ูˆุงู„ุชุงู†ูŠ code for a protein ุณู„ุณุงูƒุฉ ู„ุจุฑูˆุชูŠู†
116
00:10:27,400 --> 00:10:33,080
ู„ู…ุง ุงู„ุชุงู†ูŠู† ูŠุฌุชู…ุนูˆุง ู…ุน ุจุนุถ ุจุชูƒูˆู†ูˆุง ุจุฑูˆุชูŠู† ู‚ูˆูŠ ุฌุฏุง
117
00:10:33,080 --> 00:10:40,060
ูˆุจูŠุดุชุบู„ on both have both function ูˆุจุงู„ุชุงู„ูŠ
118
00:10:41,590 --> 00:10:45,170
It can push the proliferation differentiation
119
00:10:45,170 --> 00:10:51,650
process in a novel manner ูˆ ุจุงู„ุฐุงุช ููŠ ุฃูˆู„ ู‡ุฐู‡
120
00:10:51,650 --> 00:10:56,650
ุงู„ู…ุฑุงุญู„ Translocation ุชุณุนุฉ ูˆ ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู† ุฒูŠ ู…ุง
121
00:10:56,650 --> 00:11:05,390
ุงู†ุชูˆุง ุดุงูŠููŠู† ุงุชู†ูŠู† ูˆ ุนุดุฑูŠู† ูƒุงู† ู‡ุฏุง ู‡ูˆ ู…ุงุดูŠ ูˆ ุณุงุฑูŠูƒ
122
00:11:05,390 --> 00:11:09,110
ุจุนุฏ ุงู„ translocation
123
00:11:11,640 --> 00:11:16,720
translocation ุฃูŠุถุง ุตูˆุฑุฉ ุชุงู†ูŠุฉ ุจุชูˆุถุญ ุจุงู„ุฑุณู… ุงู„ุฌุฒุก
124
00:11:16,720 --> 00:11:22,060
ุงู„ู…ู†ู‚ูˆู„ ูˆุงุญุฏ ุงู„ุฃุฌุฒุงุก ู‡ุฐู‡ ู‡ูŠ ุงู„ู…ู†ู‚ูˆู„ุฉ ู‡ุฐู‡ ูˆุงุญุฏ
125
00:11:22,060 --> 00:11:27,240
ุจุฑูˆุญุงู† ูˆุงู„ุชุงู†ูŠ ุจุฌู‡ุงู† ู…ุงุดูŠ ูˆ ู‡ุฐุง ุงู„ุฌุฒุก ุจุฑูˆุญุงู†
126
00:11:27,240 --> 00:11:32,800
ูุงู„ุชู†ูŠู† ูˆุนุดุฑูŠู† ูˆุงุชู†ูŠู† ูˆุนุดุฑูŠู† ุฌุฒุก ุจุฑูˆุญ ุนู„ู‰ ุนู„ู‰ ุชุณุนุฉ
127
00:11:32,800 --> 00:11:37,320
ุทุจุนุง
128
00:11:37,320 --> 00:11:43,990
ุงู„ television ูƒู†ูŠุฒูˆู‡ูˆ ุนุจุงุฑุฉ ุนู† ุงู„ุจุฑูˆุชูŠู†ุฒ ุจุชู„ุนุจ ุฏูˆุฑ
129
00:11:43,990 --> 00:11:48,850
ูƒุจูŠุฑ ููŠ ุงู„ signal transduction ูˆุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠ ุงู„
130
00:11:48,850 --> 00:11:56,170
BCR ABL ู‡ูˆ ุนุจุงุฑุฉ ุนู† ุชุงุฑูŠุฒูŠู† ูƒุงูŠู†ูŠุฒ activity ูˆ this
131
00:11:56,170 --> 00:12:01,250
activity ุจุชู„ุนุจ ุฏูˆุฑ ูƒุจูŠุฑ ููŠ growth advantage to the
132
00:12:01,250 --> 00:12:05,030
lycanic cell ุดูˆ ุจุชุนู…ู„ุŸ ูŠุนู†ูŠ increase proliferation
133
00:12:05,030 --> 00:12:09,030
and cytokine independent ูŠุนู†ูŠ ุจุชุจุทุฑ ุชุฑุฏ ุนู„ู‰ ุงู„
134
00:12:09,030 --> 00:12:15,580
growth factorุจูŠู†ู…ูˆ ู†ู…ูˆ ู…ุทุฑุฏูˆู† regulatory mechanism
135
00:12:15,580 --> 00:12:21,700
ุจูŠุตูŠุฑ ููŠู‡ ู†ูˆุน ู…ู† ุงู„ autonomy ูŠุนู†ูŠ ุงู„ุญูƒู… ุงู„ุฐุงุชูŠ
136
00:12:21,700 --> 00:12:26,580
ู„ู„ุฎู„ูŠุฉ ุชุชุญูƒู… ู†ูุณู‡ุง ุจู†ูุณู‡ุง ุฃูŠุถุง ุจูŠุนู…ู„ inhibition ู„ู„
137
00:12:26,580 --> 00:12:32,740
-amortosis ุจูŠุฎูู
138
00:12:32,740 --> 00:12:37,020
ุงู„ adhesion ุงู„ู…ูˆู„ูŠูƒูŠูˆู†ูŠ ูˆุจุงู„ุชุงู„ูŠ ุชุชุญุฑุฑ ุงู„ุฎู„ูŠุฉ ุฃูƒุชุฑ
139
00:12:37,020 --> 00:12:40,400
ููŠ ุญุฑูƒุชู‡ุง
140
00:12:43,500 --> 00:12:49,980
ูƒูŠู ู†ุดุฎุต ุงู„ู…ุฑูŠุถ ุงู„ู€CMLุŸ ู‚ุงู„ูˆุง ุฃูˆู„ ู…ุง ุจูŠุฌูŠ ู…ุฑูŠุถ
141
00:12:49,980 --> 00:12:55,480
ุงู„ู€CML ุจูŠูƒูˆู† ุจูŠุนุงู†ูŠ ู…ู† ุงู„ู‚ุงุฏูŠ ุจูŠุจู‚ู‰ ู‚ุงุนุฏ
142
00:12:55,480 --> 00:13:01,700
increasing splenomegaly ูˆุทุจุนุง ู„ู…ุง ุจูŠูƒุจุฑ ุงู„ู€Spleen
143
00:13:01,700 --> 00:13:06,480
ุจูŠุตูŠุฑ ููŠู‡ discomfort ูˆ pain ูˆ indigestion
144
00:13:09,040 --> 00:13:13,260
ู…ุฑุฉ ุงุชู†ูŠู† Defractory Anemia ูˆู…ู† ุตูุงุช ุงู„ุงู†ูŠู…ูŠุง ุงู„
145
00:13:13,260 --> 00:13:17,560
pallor ูˆ ุงู„ weakness ูˆ ุงู„ุชุงูƒูŠูƒุงุฑุฏูŠุง ู…ุฑุฉ ุชู„ุงุชุฉ
146
00:13:17,560 --> 00:13:23,040
Brosing ูˆ ู…ู…ูƒู† ูŠุตูŠุฑ ุนู†ุฏู‡ ุงุจุณุช ุจุฑูˆุฒูŠู† ูŠุนู†ูŠ bleeding
147
00:13:23,040 --> 00:13:31,800
under the skin ุงูˆ ุงุจุณุชaxis ูŠุนู†ูŠ
148
00:13:31,800 --> 00:13:37,620
ุฑุนูุฉ ุงูˆ bleeding from the noseู†ุชูŠุฌุฉ ุงู„ู€ Abnormal
149
00:13:37,620 --> 00:13:43,620
Platelet Function ุจูŠุตูŠุฑ ููŠู‡ ุฌุงูˆุช ูˆู‡ุฐุง ู…ุญุตู„ุฉ ุชูˆุฑูŠู†ุง
150
00:13:43,620 --> 00:13:47,860
ุงู„ impairment ู„ุฅู† ููŠู‡ุง ุงูŠุจุงุฑูŠูˆุฑูŠูƒูŠู…ูŠุง ู†ุชูŠุฌุฉ ุชูƒุณูŠุฑ
151
00:13:47,860 --> 00:13:56,460
ุงู„ุฎู„ุงุฆูŠุฉ ูŠุนู†ูŠ ุณู„ุทุงู†ูŠุฉ ุซู… ุงู„ visual disturbances
152
00:13:56,460 --> 00:14:03,200
ุงู„ู„ูŠ ู…ู…ูƒู† ุชุญุตู„ ู†ุชูŠุฌุฉ ุงู„ุฃู†ูŠู…ูŠุง ูˆู…ู…ูƒู† ุชุญุตู„ ู†ุชูŠุฌุฉุชุฌู…ุน
153
00:14:03,200 --> 00:14:07,320
ุงู„ูŠูˆุฑูŠูƒ ุฃุณุฏ ููŠ ุฃู…ุงูƒู† ู…ุฎุชู„ูุฉ ู…ู† ุงู„ุฌุณู… ุจู…ุง ููŠู‡ุง
154
00:14:07,320 --> 00:14:14,780
ุฃู…ู„ุงุญ ูˆุตู„ุฉ ุงู„ุนูŠู† increase requirement to
155
00:14:14,780 --> 00:14:18,520
chemotherapy to maintain remission ูƒู„ู…ุง ุฒุงุฏ ุงู„ุนุฏุฏ
156
00:14:18,520 --> 00:14:22,760
ุชุจุน ุงู„ white blood cell abnormal ู„ูˆ ูƒูŠู…ูŠูƒ ุณูŠู„ ูƒู„ู…ุง
157
00:14:22,760 --> 00:14:28,440
ุฒู‰ ู…ุฑูŠุถ ูŠุญุชุงุฌ ูƒูŠู…ูˆุซูŠุฑุงุจูŠ ุจูƒู…ูŠุฉ ุฃูƒุจุฑ ุซู… massive
158
00:14:28,440 --> 00:14:31,780
increase ู„ู„ granulocytes
159
00:14:34,280 --> 00:14:38,220
ุฃูƒูŠุฏ ู„ู‡ ูƒูŠู…ูŠุง ุงู†ู‡ ุฏุงุฆู…ุง ููŠ increase ููŠ ุงู„ white
160
00:14:38,220 --> 00:14:44,480
blood cell ุทูŠุจ ูƒูŠู ู†ุดุฎุต ู…ุฑูŠุถ ุงู„ CML ูŠุนู†ูŠ ุจู†ุนู…ู„ CBC
161
00:14:44,480 --> 00:14:48,660
ูˆ ุบุงู„ุจุง ุงู„ white blood cell ุจุชูƒูˆู† ุงูƒุชุฑ ู…ู† ุฎู…ุณูŠู†
162
00:14:48,660 --> 00:14:57,540
ุงู„ู ูˆุจุนุฏ ู…ุฑุงุช ุจุชูˆุตู„ ุงูƒุชุฑ ู…ู† ุฎู…ุณู…ุงุฆุฉ ุงู„ู ููŠ ูƒู„
163
00:14:57,540 --> 00:15:03,700
millimeter cube cubic millimeterูˆุจุชูƒูˆู† ููŠู‡ ุงู†ูŠู…ูŠุง
164
00:15:03,700 --> 00:15:08,880
ูˆุงู„ุงู†ูŠู…ูŠุง ู‡ูŠ normochromic ูˆุงู„ู€ platelet ููŠ ุงู„ุจุฏุงูŠุฉ
165
00:15:08,880 --> 00:15:13,920
ุจุชูƒูˆู† ุงู…ุง ุนุงู„ูŠุฉ ูˆุงู…ุง normal ูˆุงู…ุง ูˆุงุทูŠุฉ ู„ูˆ ุนู…ู„ู†ุง
166
00:15:13,920 --> 00:15:18,560
peripheral blood ู‡ู„ุงุฌูŠ ููŠู‡ ุฒูŠุงุฏุฉ ููŠ ุงู„ circulating
167
00:15:18,560 --> 00:15:23,620
basophilูˆุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ู‡ุฏุง ู‡ูŠ ุงู„ glass
168
00:15:23,620 --> 00:15:29,940
ุงู„ู…ูˆุฌูˆุฏุฉ ูˆููŠู‡ ู…ุงุชุด ูˆุฑุณู„ ู…ุชูƒู„ู…ุฉ ุฏู‡ ู‡ูŠ ู…ุงุชุด ูˆุฑุณู„
169
00:15:29,940 --> 00:15:35,880
ุงู†ู…ุง ุงู„ glass ุฏู‡ ู‡ูŠ ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ peripheral blood
170
00:15:35,880 --> 00:15:39,600
ูˆ ู‡ุฐุง ููŠ ุงู„ ambivalent blood ูˆ ู‡ุฐุง ุจุฑุถู‡ peripheral
171
00:15:39,600 --> 00:15:45,090
bloodุชุดูˆููˆู† ู†ูŠูˆุชุฑูˆููŠู„ูŠุง ุงู„ู„ู‰ ู…ูˆุฌูˆุฏ ู„ูƒู† ุจุงู„ุงุถุงูุฉ
172
00:15:45,090 --> 00:15:51,450
ู„ู„ู†ูŠูˆุชุฑูˆููŠู„ูŠุง ููŠ ุงู„ู„ู‰ ู‡ูˆ abnormal or immature cell
173
00:15:51,450 --> 00:16:00,170
ู‡ู‰ ุฏู‰ metamylocytes ู‡ู‰ ุฏู‰ blast ู‡ู‰ ู†ุจุฑูˆ ู…ูŠู„ูˆ ุณุงูŠุชุณ
174
00:16:00,170 --> 00:16:05,630
ูˆู‡ูƒุฐุง ู‡ู‰ ุฏูˆู„ ุงู„ุฎู„ุงูŠุง ุจุฑุถู‡ immature
175
00:16:07,160 --> 00:16:11,700
ูููŠู‡ ุนุจุงุฑุฉ ุนู† ููŠู„ู… ุจูŠูƒูˆู† mixed of mature and
176
00:16:11,700 --> 00:16:16,860
immature self ูˆู…ุนุธู… ู…ุฑุงุญู„ ุงู„ maturation ุจุชูƒูˆู†
177
00:16:16,860 --> 00:16:21,320
ู…ูˆุฌูˆุฏุฉ ุทูŠุจ ุฅูŠุด ููŠู‡ุง ุฌูˆุงู‡ุฑ ุชุดุฎูŠุตูŠุฉ ุฃุฎุฑู‰ ุฌุงู†ูˆุง ุจู†ุนู…ู„
178
00:16:21,320 --> 00:16:27,190
ุชุชุฑููŠู‡ ู„ูƒู„ุงู… ูุงุณูุงุชูŠู‡ scoringูˆุบุงู„ุจุง ุงูŠุด ูŠุนู†ูŠ ูŠุนู†ูŠ
179
00:16:27,190 --> 00:16:32,790
ุจุฏุฃูˆุง ุจุณุจูˆู‡ุง ุจุงู„ alkaline phosphatase ูˆ ุจุจุฏุฃ ุงุนุฏ
180
00:16:32,790 --> 00:16:40,450
ุงู„ู„ูŠ ู‡ูˆ ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ู…ุงุฎุฏุฉ ุณุจู‚ู‡ุง ูˆุบุงู„ุจุง ู„ุฃู†ู‡ุง
181
00:16:40,450 --> 00:16:45,470
abnormal cell ุจูŠูƒูˆู† ุงู„ alkaline phosphatase
182
00:16:45,470 --> 00:16:49,530
function ูˆุงุทูŠู‡ ู…ุด ู…ูˆุฌูˆุฏ ูˆุจุงู„ุชุงู„ูŠ ุจุชูƒูˆู† ู‚ุฏุฑุชู‡ุง ู‚ู„ูŠู„
183
00:16:49,530 --> 00:16:57,920
ุงู„ุจูˆู…ุจุฑูˆ is hypercellularwith granulopoietic
184
00:16:57,920 --> 00:17:02,860
predominance ุงูƒุชุฑ ุงุดูŠ ู„ุฌุฑุงู†ูŠู„ูˆ ุณุงูŠุชุณ ูˆู„ูˆ ุนู…ู„ู†ุง
185
00:17:02,860 --> 00:17:09,920
study of genetics ุณู†ุดูˆู ูู„ุงู†ู„ููŠุง ูƒุฑูˆู…ุงุฒูˆู† ูˆ ุงูŠุถุง
186
00:17:09,920 --> 00:17:16,820
ู„ูˆ ุนู…ู„ู†ุง P12 and P12 binding capacity ุจุชูƒูˆู† ุนุงู„ูŠุฉ
187
00:17:16,820 --> 00:17:23,350
ู„ูŠุดุŸู‡ุฐู‡ ู†ู‚ุทุฉ ู…ู‡ู…ุฉ ุฌุฏุง ู„ุงู† ุงุชูู‚ู†ุง ุงู† ุงู„ career of
188
00:17:23,350 --> 00:17:30,190
B12 ู‡ูˆ ู…ู† ุชู„ุช ุฃู†ูˆุงุน ุงู„ู†ูˆุน ุงู„ุชุงู†ูŠ ู‡ูˆ significant
189
00:17:30,190 --> 00:17:38,110
ุงู„ู†ูˆุน ุงู„ุฃูˆู„ ูˆุงู„ุชุงู„ุช ู‡ุฏูˆู„ุฉ ุจูŠุชุตู†ุนูˆุง ู…ู† ุงู„ white
190
00:17:38,110 --> 00:17:41,710
blood cell ุฌุฑุงู†ูŠุงู„ ูˆุงู„ุฌุฑุงู†ูŠุงู„ ุงู„ุนุงู„ูŠุฉ ูุจุงู„ุชุงู„ูŠ
191
00:17:41,710 --> 00:17:45,170
ุงู„ุชุฑูƒูŠุฒ ุชุจุนู‡ู… ุจูƒูˆู† ุนุงู„ูŠ ูˆุจุงู„ุชุงู„ูŠ ุจูŠู…ุดูƒูˆุง ุงู„
192
00:17:45,170 --> 00:17:48,940
vitamin B12 ุจูƒู…ูŠุงุช ุฃูƒุจุฑูˆ ู‡ุคู„ุงุก ู‡ู… ุงู„ู†ุงุณ ุงู„ู„ูŠ
193
00:17:48,940 --> 00:17:53,140
ุจูŠุณู…ูˆู‡ู… non significance ุงุฑุจุนูŠู† ุฏู„ ูˆุจุงู„ุชุงู„ูŠ
194
00:17:53,140 --> 00:17:59,120
ุจูŠู…ุดูŠูƒูˆุง ุงู„ vitamin ูˆ ุจูŠุจู‚ูˆุง ู…ุณูƒูŠู† ููŠู‡ ูˆุจุงู„ุชุงู„ูŠ
195
00:17:59,120 --> 00:18:07,060
ุชุฑูƒูŠุฒู‡ู… ุนุงู„ูŠ ููŠ ุงุณุชูŠุฑุงู† ุญุงุฌุฉ ุชุงู†ูŠุฉ ู†ุนู…ู„ ูŠูˆุฑูŠูƒ ุฃุณุฏ
196
00:18:07,060 --> 00:18:13,070
ูˆ ุจูŠูƒูˆู† ุนุงู„ูŠ ู†ุชูŠุฌุฉ ุชูƒุณุฑ ุงู„ุฎู„ุงูŠุงู…ุง ู‡ูŠ ุงู„ู…ุฑุงุญู„ ุงู„ู„ูŠ
197
00:18:13,070 --> 00:18:17,130
ุจุชู…ุฑ ููŠู‡ุง ุงู„ู€CMLุŸ ูƒุงู†ูˆุง ููŠู‡ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
198
00:18:17,130 --> 00:18:18,230
ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
199
00:18:18,230 --> 00:18:21,070
ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
200
00:18:21,070 --> 00:18:21,690
ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
201
00:18:21,690 --> 00:18:21,730
ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
202
00:18:21,730 --> 00:18:21,790
ุชู„ุช ู…ุฑุงุญู„ ุชู„ุช ู…ุฑุงุญู„
203
00:18:40,850 --> 00:18:45,810
ุงู„ู€ accelerated phase ู‚ุงู„ูˆุง ู‡ู†ุง ุจูŠุตูŠุฑ ููŠ ุงู†ุชู‚ุงู„ ู„
204
00:18:45,810 --> 00:18:52,190
phase ุชุงู†ูŠ ุจูŠุณู…ูˆู‡ accelerated ู…ุชุณุงุฑุน ูˆ ุงู„ู„ูŠ ุจูŠุตูŠุฑ
205
00:18:52,190 --> 00:18:53,970
ููŠ ู‡ุฐุง ุงู„ phase ุงู†ู‡ ุจูŠุตูŠุฑ refractory
206
00:18:53,970 --> 00:18:59,450
refractoriness to treatment ุจุชุฒูŠุฏ ุงู„ refractory to
207
00:18:59,450 --> 00:19:07,950
treatment ูˆ ู‡ุฐุง ู†ุชูŠุฌุฉ ูŠุนู†ูŠ ุงู„ู„ูŠ ู‡ูˆ ุงูƒุชุณุงุจ ุงู„ู…ุฑูŠุถ
208
00:19:07,950 --> 00:19:12,110
mutation ุฌุฏูŠุฏุฉูˆุจุงู„ุชุงู„ูŠ ุตุงุฑ ููŠู‡ ุฒูŠุงุฏุฉ ููŠ ุงู„
209
00:19:12,110 --> 00:19:17,470
resistance to therapy ู…ุงุฐุง ูŠู…ูŠุฒ ู‡ุฐุง ุงู„ู…ุฑูŠุถ ู‚ุงู„ูˆุง
210
00:19:17,470 --> 00:19:20,830
ููŠ ูˆุฌูˆุฏ 15% ุจู„ุงุณุช ููŠ ุงู„ bone marrow ุงูˆ ุงู„
211
00:19:20,830 --> 00:19:25,570
peripheral blood ูˆ ุงูƒุชุฑ ูˆุฌูˆุฏ ุงูƒุชุฑ ู…ู† 30% ุจู„ุงุณุช ูˆ
212
00:19:25,570 --> 00:19:30,470
bromielocyte ููŠ ุงู„ peripheral blood ุงูƒุชุฑ ู…ู† 20%
213
00:19:30,470 --> 00:19:38,850
ุจูŠุฒูˆููŠู„ ูˆ ุงู‚ู„ ู…ู† 100000 ู„ุจู„ูŠุชู„ุชูˆู‡ูŠ ูƒู…ุง ู‚ู„ู†ุง ุงูƒุชุณุงุจ
214
00:19:38,850 --> 00:19:41,690
ู„ู€ mutation ุฌุฏูŠุฏุฉ ูููŠ ูƒุฑู…ูˆุฒูˆู…ุฉ ุงู„ abnormality
215
00:19:41,690 --> 00:19:46,050
ุฌุฏูŠุฏุฉ ูˆู…ู† ุฃุดู‡ุฑ ุงู„ addition ู„ูƒุฑู…ูˆุฒูˆู…ุฉ ุงู„
216
00:19:46,050 --> 00:19:51,610
abnormality ู‡ูŠ Trisomy 8 Increase
217
00:19:51,610 --> 00:19:56,130
ุจูŠู‚ูˆู… ู…ุนุฑูˆูุฉ ููŠ ุจุฑูˆุณุณ ูˆููŠ
218
00:19:56,130 --> 00:20:01,930
ุงู„ plastic phase ุงู„ plastic should exceed ุชู„ุงุชูŠู†
219
00:20:01,930 --> 00:20:03,430
ูุงู„ู…ูŠุฉ ููŠ ุงู„ุจุฑูุฑุงู„ุจุท
220
00:20:07,560 --> 00:20:16,260
ูˆู‡ุฐุง ุบุงู„ุจุง ุนุจุงุฑุฉ ุนู† evolution of CML ูˆูƒุฃู†ู‡ุง ุงู„ู€
221
00:20:16,260 --> 00:20:21,980
CML ุจุชุฌู„ุจ ู„ู€ acute phase ู„ุฃู†ู‡ ู„ู…ุง ุนุฑูู†ุง ุงู„ acute
222
00:20:21,980 --> 00:20:26,660
leukemia ู‚ู„ู†ุง ู„ุงุฒู… ูŠูƒูˆู† ููŠู‡ blast ุจู†ุณุจุฉ 30% ูู…ุง
223
00:20:26,660 --> 00:20:31,180
ููˆู‚ ููŠ ุงู„ chronic leukemia ูŠูˆู… ู…ุง ุชุฌู„ุจ ูŠูˆู… ู…ุง ูŠุฒูŠุฏ
224
00:20:31,180 --> 00:20:34,320
ุนุฏุฏ ุงู„ blast ู„ 30% ูู…ุง ููˆู‚ ุชุฌู„ุจ ู„
225
00:20:37,280 --> 00:20:42,160
acute leukemia ูˆ ุจุงู„ุชุงู„ูŠ ุงุฐุง ูˆุตู„ุช ู„ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ
226
00:20:42,160 --> 00:20:45,720
ุจูŠูƒูˆู† ุงู„ู…ุฑูŠุถ ุนู†ุฏู‡ anemia ูˆ ุนู†ุฏู‡ neutropenia ูˆ ุนู†ุฏู‡
227
00:20:45,720 --> 00:20:51,240
thrombocytopenia ุจุดูƒู„ ูˆุงุถุญ plastic phase ุฒูŠ ู…ุง
228
00:20:51,240 --> 00:20:56,840
ู‚ู„ู†ุง ููŠ ู…ุนุธู… ุงู„ุญุงู„ุงุช ุงู„ accelerated phase ุจูŠุชุจุนูˆุง
229
00:20:56,840 --> 00:21:02,160
plastic phase ูˆ ุทุจุนุง ููŠ ู‡ุฐุง ุงู„ phase ุจูŠูƒูˆู†
230
00:21:02,160 --> 00:21:07,440
refractory to treatment sustained ุจู…ุนู†ู‰ ุฏุงุฆู…ูˆ ุงู„ู€
231
00:21:07,440 --> 00:21:12,860
Blast cell count ุจุชุฒูŠุฏ ูˆ ุงู„ physical symptoms
232
00:21:12,860 --> 00:21:19,880
ุจุชุฒูŠุฏ ุดูˆุก ูˆ ุงู„ diagnostic criteria for the blast
233
00:21:19,880 --> 00:21:22,720
phase ู‡ูˆ ุงู„ blast crisis
234
00:21:27,200 --> 00:21:30,980
ุงู„ู„ูŠ Circulating Blast Cell Count Should Exceed 30
235
00:21:30,980 --> 00:21:36,440
% ู…ู† ุงู„ Total Leukocyte Count ูˆุฒูŠ ู…ุง ู‚ู„ุชู„ูƒูˆุง ุฏู‡ ูˆ
236
00:21:36,440 --> 00:21:40,320
ูƒุฃู† ุงู„ anemia .. sorry ูˆ ูƒุฃู† ุงู„ chronic leukemia
237
00:21:40,320 --> 00:21:47,920
ุจุชุฌู„ุจ ู„ู…ูŠู†ุŸ ู„ acute leukemia ูˆ ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉ ุงู„
238
00:21:47,920 --> 00:21:55,250
blast ุฒูŠุงุฏุฉ ุงู„ blast ุจู‡ุฐุง ุงู„ุนุฏุฏ ุงู„ู…ุญูˆุฑุจูŠุคุฏูŠ ุฅู„ู‰
239
00:21:55,250 --> 00:22:02,110
ุฒูŠุงุฏุฉ ููŠ ุงู„ุงู†ูŠู…ูŠุง ุจุณุจุจ ู†ุชุฑูˆุจูŠู†ูŠ ุฃูˆ ุซุฑูˆู…ุจูˆุณูŠุชูˆุจูŠุง
240
00:22:02,110 --> 00:22:09,030
ู‡ุฐุง ุฌุฏูˆู„ ุจูŠูุฑู‚ู„ูŠ ู…ุง ุจูŠู† ุงู„ ุชู„ุงุชุฉ different phases
241
00:22:09,030 --> 00:22:12,650
of chronic myeloid leukemia ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู†
242
00:22:12,650 --> 00:22:15,650
median duration ููŠ ุงู„ chronic phase ุงู„ู…ุฑูŠุถ ู…ู…ูƒู†
243
00:22:15,650 --> 00:22:20,010
ูŠุนูŠุด ู…ู† ุฎู…ุณุฉ ู„ุณุช ุณู†ูˆุงุช ุจูŠู†ู…ุง ุงู„ accelerated phase
244
00:22:20,010 --> 00:22:25,830
ุชุจุฏุฃ ู…ุฑุญู„ุฉ ู‚ู„ูˆ ุนู…ุฑ ุงู„ phase ู‡ุฐุง ู„ุง ูŠุชุฌุงูˆุฒ ุณุชุฉ
245
00:22:25,830 --> 00:22:32,090
ู„ุชุณุนุฉ ุดู‡ูˆุฑ ุฅุฐุง ุฏุฎู„ ุงู„ู…ุฑูŠุถ ููŠ blast phase ุจุตู…ุฏุด
246
00:22:32,090 --> 00:22:38,630
ุฃูƒุชุฑ ู…ู† ุชู„ุงุชุฉ ุฃุณุงุช ุดู‡ูˆุฑุงู„ู€ White PCs ู‡ูŠ ุนุงู„ูŠุฉ ููŠ
247
00:22:38,630 --> 00:22:42,370
ุงู„ู€ Chronic Phase ุฃูƒุชุฑ ู…ู† 20 ุฃู„ู ูˆู‡ูŠ ุชุณุชู…ุฑ ุนุงู„ูŠุฉ
248
00:22:42,370 --> 00:22:47,290
ุจุณ ุญุณุจ ุงู„ู…ุฑุญู„ุฉ ุงู„ุฒู…ู†ูŠุฉ ุงู„ู„ูŠ ุจุชุชู… ููŠู‡ุง ุงู„ูุญุต ุจูŠูƒูˆู†
249
00:22:47,290 --> 00:22:50,570
ููŠู‡ ุฒูŠุงุฏุฉ ููŠ ุงู„ู€ White Blood Cell ุงู„ู€ Blast ููŠ
250
00:22:50,570 --> 00:22:55,730
ุงู„ุจุฏุงูŠุฉ ุจูŠูƒูˆู† ุณูุฑ ู„ูƒู† ุจุชุจุฏุฃ ุชุฒูŠุฏ ู„ุบุงูŠุฉ ู…ุง ุชุตู„ ู„ู€
251
00:22:55,730 --> 00:23:00,550
30% ููŠ ุงู„ู€ Plastic Phase ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ Acute ูˆูƒุงู†ู‡ุง
252
00:23:00,550 --> 00:23:06,400
ุฌู„ุจุฉ ู„ู€ Acute ุจูŠุธู‡ุฑ ููŠู‡ ุงู„ุนุงู„ูŠุฉ ูˆู‡ูŠ ุจุชุณุชู…ุฑ ุนุงู„ูŠุฉููŠ
253
00:23:06,400 --> 00:23:11,180
ุงู„ุจุฏุงูŠุฉ ุจุชูƒูˆู† ุนุงู„ู‰ ุงูˆ normal ุซู… ููŠ ุงู„ู†ู‡ุงูŠุฉ ุจุชุตูŠุฑ
254
00:23:11,180 --> 00:23:18,300
decreased ุงู„ myeloid hyperplasia ุทุจุนุง ูƒู„ ู…ุฑู‡ ุจูŠูƒูˆู†
255
00:23:18,300 --> 00:23:24,340
hypercellularity of myeloid series ุณุงุชุฑูˆุฌูŠู†ุงุซูŠูƒ ููŠ
256
00:23:24,340 --> 00:23:28,920
ู„ุงุฏู„ููŠู‡ ูƒุฑู…ุฒูˆู… ููŠ ูƒู„ ู…ุฑุงุญู„ PCR APL positive ููŠ ูƒู„
257
00:23:28,920 --> 00:23:35,520
ุงูŠุด ุงู„ู…ุฑุงุญู„ูƒูŠู ู…ุบุงู„ุฌ ุงู„ู€CML ูƒุงู†ูˆุง ูŠุชุนุงู„ุฌูˆุง ุจุฃูƒุชุฑ
258
00:23:35,520 --> 00:23:40,180
ู…ู† ุชู‚ู†ูŠุงุช ู†ู…ุฑุง ูˆุงุญุฏ ูƒูŠู…ูˆุซูŠุฑุงุจูŠ ู†ู…ุฑุง ุงุชู†ูŠู† ุชูŠุฑูˆุฒูŠู†
259
00:23:40,180 --> 00:23:43,400
ูƒูŠู†ูŠุฒ ุงู†ู‡ูŠุจุชูˆุฑ ู†ู…ุฑุง ุชู„ุงุชุฉ interferon alpha ู†ู…ุฑุง
260
00:23:43,400 --> 00:23:47,560
ุฃุฑุจุน stem cell transplant ูˆุงู„ุชูŠุฑูˆุฒูŠู† ูƒูŠู†ูŠุฒ
261
00:23:47,560 --> 00:23:52,700
ุงู†ู‡ูŠุจุชูˆุฑ ูุฏู‡ ู‡ูˆ ูˆุจุฑ ุนู† ุนู„ุงุฌ ู†ุนู…ู„ ููŠู‡ plucking
262
00:23:52,700 --> 00:23:59,540
ู„ู„ุชูŠุฑูˆุฒูŠู† ูƒูŠู†ูŠุฒ ุงู„ู„ูŠ ู‡ูˆ substrate
263
00:24:05,090 --> 00:24:11,390
ุงู„ุนู„ุงุฌ ุงุณู…ู‡ Glyvec ุงุณู…ู‡ Glyvec ููŠ ุงู„ูˆุถุน ุงู„ุทุจูŠุนูŠ ุงู„
264
00:24:11,390 --> 00:24:17,130
PCR APL ู…ุงุดูŠ ุงู„ substrate ุชุจุนู‡ ูŠุญุชุงุฌ ุฅู„ู‰ ุทุงู‚ุฉ
265
00:24:17,130 --> 00:24:26,070
ุชุงูŠุฑูˆุฒูŠู†ูƒุงู†ูŠุฒ ูˆุจุงู„ุชุงู„ูŠ ุจูŠุดุชุบู„ ุจุดูƒู„ ุฒูŠ ู…ุง ู‚ู„ู†ุง ูู„ูˆ
266
00:24:26,070 --> 00:24:30,460
ุนู…ู„ู†ุง blocking ู„ู„Tyrosine Kinase Activity ุจู…ุนู†ู‰
267
00:24:30,460 --> 00:24:36,320
Blocking ู„ู„ู€ATP Source ุจู…ุนู†ู‰ ุฃู† ุงู„ุจุฑูˆุชูŠู† ู„ู† ูŠูƒูˆู†
268
00:24:36,320 --> 00:24:40,900
ููˆุณููˆุฑูŠู„ุงุช ูˆุจุงู„ุชุงู„ูŠ ู…ุงููŠุด function ุงู„ุนู„ุงุฌ ู‡ุฐุง ุฃุซุจุช
269
00:24:40,900 --> 00:24:47,080
ู†ุฌุงุนุฉ ุฌูŠุฏุฉ ุฌุฏุง ูˆู…ุง ูŠู…ูŠุฒ ู‡ุฐุง ุงู„ุนู„ุงุฌ ุฃู†ู‡ ู‡ูˆ ุจุฑู‡ ุนู†
270
00:24:47,080 --> 00:24:52,240
specific treatment ุจูŠุดุชุบู„ ู„ุฌู„ุงูŠููƒ ุงู„ receptor of
271
00:24:52,240 --> 00:24:54,880
ash of kinase enzyme
272
00:24:57,670 --> 00:25:06,190
ุงู„ุจุฑูˆู…ูŠูˆุฒูŠุฒ ู„ู„ู€CML ููŠ ุงู„ุบุงู„ุจ ุชุธู‡ุฑ ุชุฌุงุฑุจ
273
00:25:06,190 --> 00:25:11,110
ูƒูŠู…ูˆุซูŠุฑุงุจูŠุฉ ู…ู…ุชุงุฒุฉ ููŠ ุงู„ููŠุฒ ุงู„ูƒุฑูˆู†ูŠูƒูŠ ู„ูƒู† ูƒู„ ู…ุง
274
00:25:11,110 --> 00:25:15,250
ุชู‚ุฏู…ู†ุง ููŠ ุงู„ููŠุฒูŠุงุช ุงู„ุชุงู†ูŠุฉ ุจูŠุตูŠุฑ ููŠู‡ุง ู…ู‚ุงูˆู…ุฉ
275
00:25:15,250 --> 00:25:21,350
ูƒูŠู…ูˆุซูŠุฑุงุจูŠุฉ ูˆุงู„ู…ูˆุช ุนุงุฏุฉ ุจูŠุตูŠุฑ ุจุณุจุจ ุชุบูŠูŠุฑ ุงู„ุฃูƒูŠูˆ
276
00:25:21,350 --> 00:25:24,970
ูˆุงู„ู‡ู…ุฑุงุฌ
277
00:25:26,340 --> 00:25:30,740
ุฃูˆ infection ูˆู†ุณุชูˆู‚ู
278
00:25:30,740 --> 00:25:43,360
ู†ุงุฎุฏ ุงุณุชุฑุงุญุฉ ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ููŠ ู‡ุฐู‡ ุงู„ู†ูˆุน
279
00:25:43,360 --> 00:25:48,040
ุงู„ุชุงู†ูŠ ู…ู† ุงู„ chronic leukemia ู‡ูˆ chronic
280
00:25:48,040 --> 00:25:52,570
lymphocytic leukemiaูˆ ุฃู†ุง ุจุญูƒูŠ ุนู„ู‰ lymphocyte ุทุจุนุง
281
00:25:52,570 --> 00:25:55,930
chronic lymphocytic leukemia ู‡ูŠ most common type
282
00:25:55,930 --> 00:25:59,610
of chronic lymphoid leukemia ุทุจุนุง ุฏูŠ ูŠูƒู† ูุฑู‚ู‡ ู…ุง
283
00:25:59,610 --> 00:26:03,630
ุจูŠู† ุงู„ chronic lymphoid ูˆ ู‡ูŠ ูƒู„ ุฃู†ูˆุงุน ุงู„ lympho ุงู„
284
00:26:03,630 --> 00:26:06,610
lymphoid leukemia ูˆ ู…ุง ุจูŠู† ุงู„ chronic lymphocytic
285
00:26:06,610 --> 00:26:12,910
leukemia ุงู„ู„ูŠ ู‡ูŠ ุงู„ ุจุชุฎุต
286
00:26:12,910 --> 00:26:19,680
ุงู„ู„ูŠ ุงุญู†ุง ุจู†ุญูƒูŠ ุนู„ูŠู‡ุง ุงู„ุขู†ุจู…ุง ุฏู‡ ุชุชู…ูŠุฒ By
287
00:26:19,680 --> 00:26:23,160
accumulation of non-proliferative mature appearing
288
00:26:23,160 --> 00:26:29,100
lymphocytes ูŠุนู†ูŠ ููŠู‡ lymphocytosis accumulation of
289
00:26:29,100 --> 00:26:32,340
non-proliferative ู„ูŠุด ุจู†ู‚ูˆู„ ูŠุนู†ูŠ ุงูŠุด non
290
00:26:32,340 --> 00:26:36,420
-proliferative or proliferationู„ุฃู† ุงู„ุฎู„ูŠุฉ ูŠูˆู… ู…ุง
291
00:26:36,420 --> 00:26:43,900
ุชุตูŠุฑ mature ุจุชูˆู‚ู ุงู†ู‚ุณุงู…ุงุชู‡ุง mature appearing ู…ุง
292
00:26:43,900 --> 00:26:49,600
ู‡ูŠ mature ู…ุธู‡ุฑู‡ุง ูƒ mature lymphocyte ูˆู…ุน ุงู†ู‡ ููŠ
293
00:26:49,600 --> 00:26:52,260
accumulation ูŠุจู‚ู‰ ููŠู‡ lymphocytosis ูˆูŠู† ุจูŠุตูŠุฑ ุงู„
294
00:26:52,260 --> 00:26:57,020
accumulationุŸ ุงู„ู„ูŠ ุจูŠุตูŠุฑ ููŠ ุงู„ blood ููŠ ุงู„ marrow
295
00:26:57,020 --> 00:27:02,000
ููŠ ุงู„ lymph nodes ููŠ ุงู„ spleen ู„ูŠุด ุจูŠุตูŠุฑ ููŠ ู‡ุฐู‡
296
00:27:02,000 --> 00:27:08,100
ุงู„ู…ูˆุงู‚ุนุŸ ู‡ุฐู‡ ุฎู„ูŠุฉ matureูˆ ู‡ุฐู‡ ุงู„ู…ูˆุงู‚ุน ู‡ูŠ ู…ูˆุงู‚ุน
297
00:27:08,100 --> 00:27:12,360
ูˆุตูˆู„ lymphocytes ู„ู‡ุง ู„ุฃู†ู‡ ุจุนุฏ ู…ุง ุชุชูƒูˆู† ููŠ ุงู„
298
00:27:12,360 --> 00:27:16,180
primary lymphoid organs ุชู†ุชู‚ู„ ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุฅู„ู‰ ุงู„
299
00:27:16,180 --> 00:27:19,600
secondary lymphoid organs ูˆุจุงู„ุชุงู„ูŠ ู…ู† ุฎู„ุงู„ ุงู„
300
00:27:19,600 --> 00:27:23,200
blood ูˆุจุงู„ุชุงู„ูŠ ู…ู…ูƒู† ุชุตู„ ุงู„ spleen ู…ู…ูƒู† ุชุตู„ ุงู„
301
00:27:23,200 --> 00:27:30,030
lymph nodes ูˆ ู‡ูƒุฐุงู…ุงุฐุง ูƒุงุฑูƒุชุฑุณุชูŠูƒุฒ of CLLุŸ ู‚ุงู„ูˆุง
302
00:27:30,030 --> 00:27:36,230
most cases the cell are monoclonal B lymphocyte
303
00:27:36,230 --> 00:27:42,210
ูŠุนู†ูŠ ู…ู† ู†ูˆุน B ูˆุนู„ู‰
304
00:27:42,210 --> 00:27:49,120
ุณุทุญู‡ุง CD5 positiveูˆู‡ุฐุง marker ุจูŠุณู…ูˆู‡ marker ุบุฑูŠุจ
305
00:27:49,120 --> 00:27:53,580
ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ B lymphocyte ู„ู…ุง ุญูƒูŠู†ุง ุงู„ู…ุฑุฉ ุงู„ู„ูŠ
306
00:27:53,580 --> 00:27:56,560
ูุงุชุช ุนู„ู‰ ุงู„ markers ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ุนู„ู‰ ุงู„ B
307
00:27:56,560 --> 00:28:00,980
lymphocytes ูƒู†ุง ุจุชุญู…ู„ ุฃุฑู‚ุงู… ุนุงู„ูŠุฉ ูˆ ุงู„ T
308
00:28:00,980 --> 00:28:07,100
lymphocyte ุชุญู…ู„ ุฃุฑู‚ุงู… ูˆุงุทูŠุฉ ูˆ ู‡ุฐุง ุฑู‚ู… ุฃู‚ู„ ู…ู† ุนุดุฑ
309
00:28:07,100 --> 00:28:12,420
ูู‡ูˆ ุนุจุงุฑุฉ ุนู† T cell marker ู„ูƒู†ู‡ ู…ูˆุฌูˆุฏ ุนู„ู‰ ุณุทุญ ู…ูŠู†ุŸ
310
00:28:12,420 --> 00:28:14,300
ุนู„ู‰ ุณุทุญ B cell
311
00:28:17,340 --> 00:28:23,980
ุงู„ู€ CLL ู‡ูŠ ุนุจุงุฑุฉ ุนู† mostly ุจูŠ ุณู„ ู„ูƒู† ุช ุณู„ ู…ู…ูƒู† ุชูŠ
312
00:28:23,980 --> 00:28:26,940
chronic lymphocytic leukemia ูƒุงู† okay ู„ูƒู†ู‡ุง rare
313
00:28:26,940 --> 00:28:32,740
big incidence ู„ู„ all people ู…ู† ุณุชูŠู† ู„ุชู…ุงู†ูŠู† ุณู†ุฉ
314
00:28:32,740 --> 00:28:40,740
ูู…ุง ููˆู‚and it's mostly common ููŠ ุงู„ north America
315
00:28:40,740 --> 00:28:49,360
ูˆ ููŠ ุฃูˆุฑูˆุจุง ู„ูƒู† it's very rare ููŠ ุงู„ูˆุณุท ุงู„ุนุฑุจูŠ
316
00:28:49,360 --> 00:28:54,400
ุงู„ู„ูŠ ู‡ูˆ ููŠ ุงู„ุดุฑู‚ ุงู„ุฃูˆุณุท the orient people ุงู„ู„ูŠ ู‡ูˆ
317
00:28:54,400 --> 00:29:00,140
ุงู„ู†ุงุณ ุงู„ุดุฑู‚ูŠุฉaffect men twice as often as women
318
00:29:00,140 --> 00:29:04,660
ูƒุงู„ุนุงุฏุฉ ุงู„ male ู†ุตูŠุจู‡ ุฃูƒุชุฑ ูˆ ุงู„ incidence rate
319
00:29:04,660 --> 00:29:09,460
ุดูˆููˆุง ู‚ุฏุงุด ู…ุฎุงุฑู†ุฉ ุจุงู„ chronic myeloid 300 ุญุงู„ุฉ ู„ูƒู„
320
00:29:09,460 --> 00:29:13,900
100 ุฃู„ู ุญุงู„ุฉ ู…ู† ุงู„ population ููŠ ุงู„ chronic
321
00:29:13,900 --> 00:29:17,320
myeloid leukemia ุฏูˆู„ ู…ู† ุญุงู„ุฉ ู„ุญุงู„ุชูŠู† ู„ูƒู„ 100 ุฃู„ู
322
00:29:17,320 --> 00:29:24,080
ูู‡ู… 300 ุญุงู„ุฉ ู„ูƒู„ 100 ุฃู„ู ุญุงู„ุฉ ู…ู† ุงู„ populationู…ุง
323
00:29:24,080 --> 00:29:27,560
ู‡ูŠ ุงู„ูƒูˆู…ูˆุฌูŠู†ูŠุณูŠุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉุŸ ู‚ุงู„ูˆุง ุงู† ุงู„ูˆุงู‚ุน
324
00:29:27,560 --> 00:29:35,760
ุงู„ุฌูŠู†ูŠูƒูŠ ูƒุงู† ูŠุณุชุฎุฏู… ู„ุนุจุงุฑุฉ ุนู† ุฑูˆู„ ููŠ ุนุฏุฏ ูƒุจูŠุฑ ู…ู†
325
00:29:35,760 --> 00:29:40,260
ุงู„ู€ CLM. ุงู„ูˆุงู‚ุน ุงู„ุฌูŠู†ูŠูƒูŠ ู‡ูˆ ุงู„ุฃุณุงุณ ููŠ ุงู„ู„ูŠ ู‡ูˆ
326
00:29:40,260 --> 00:29:44,780
ุงู„ุฎู„ู„ ููŠ ุงู„ูƒุฑูˆู…ุฒูˆู…ุงุช ู‡ูˆ ุงู„ุฃุณุงุณ ู„ู„ูƒูˆู…ูˆุฌูŠู†ูŠุณูŠุง ุงู„ู„ูŠ
327
00:29:44,780 --> 00:29:50,640
ุจูŠุตูŠุฑ. ููˆุงุฌู‡ูˆุง ูƒู„ูˆู…ุฉ ุงู„ูƒุฑูˆู…ุฒูˆู…ุฉ ุงู„ู€ abnormality ููŠ
328
00:29:50,640 --> 00:29:56,970
ุฃูƒุชุฑ ู…ู† 50% ู…ู† ุงู„ุญุงู„ุงุชูˆ ุฃุดู‡ุฑ ู‡ุฐู‡ ุงู„ chromosome ุงู„
329
00:29:56,970 --> 00:30:02,010
abnormality ู‡ูŠ ุนุจุงุฑุฉ ุนู† trisomy 12 ูˆ ุฃูŠุถุง ููŠ
330
00:30:02,010 --> 00:30:07,450
structure abnormality chromosome 13 ูˆ 14 ูˆ 11 ูˆ
331
00:30:07,450 --> 00:30:14,730
ุทุจุนุง ุงูŠ ู…ุฑูŠุถ ุจูŠูƒูˆู† ุนู†ุฏู‡ ูƒุงุฑูŠูˆุชูŠุจูŠ positive ุจูŠ have
332
00:30:14,730 --> 00:30:16,670
bad prognosis
333
00:30:23,390 --> 00:30:30,310
ุงู„ู…ุฑุถ ู‡ูˆ ุทุจูŠุนุชู‡ slow progressive disease
334
00:30:32,150 --> 00:30:36,330
ูˆ ุฎู…ุณุฉ ูˆ ุนุดุฑูŠู† ููŠู„ู… ู„ุจู†ูŠุฉ ู…ู† ุงู„ุญุงู„ุงุช ู„ู…ุง ุจุชูŠุฌูŠ
335
00:30:36,330 --> 00:30:41,370
ู„ู„ุชุดุฎูŠุต ุจุชูƒูˆู† free of physical symptoms ู…ุง ุจุชุนุงู†ูŠ
336
00:30:41,370 --> 00:30:46,350
ู…ู† ุฃูŠ physical symptoms ูˆ ุจุชูƒุชุดู ุจุงู„ุตุฏูุฉ ูˆ ู„ูˆ ู…ุง
337
00:30:46,350 --> 00:30:53,730
ุชูƒุชุดู ุจุชูƒูˆู† ููŠู‡ unexplained absolute unbearable
338
00:30:53,730 --> 00:30:59,650
lymphocytosis ูŠุจู‚ู‰ ู‡ุฐู‡ ุฃูˆู„ ุญุงุฌุฉ ุจู†ุดูˆูู‡ุงุจูƒูˆู† ุงู„ู…ุฑูŠุถ
339
00:30:59,650 --> 00:31:04,850
ุนู†ุฏู‡ lymphocytosis ุจูƒูˆู† ุนู†ุฏู‡ either cervical or
340
00:31:04,850 --> 00:31:15,470
subclavicular or axillary lymphadenopathy ูˆ ุบุงู„ุจุง
341
00:31:15,470 --> 00:31:20,730
ุจูŠุตุงุญุจ ุงู„ lymphadenopathy splenomegaly ูŠุนู†ูŠ ุจูŠูƒูˆู†
342
00:31:20,730 --> 00:31:25,150
ููŠ enlargement ู„ู„ lymph nodes ุงู…ุง ููŠ ุงู„ cervical
343
00:31:25,150 --> 00:31:33,340
ุงูˆ ุงู„ subclavicular and orู…ุงุดูŠ auxiliary ู…ุงุดูŠ
344
00:31:33,340 --> 00:31:39,680
lymph nodes ู…ุตุงุญุจ ุฐู„ูƒ ุงู„ู„ูŠ ู‡ูˆ splenomegaly ูŠูˆู… ูŠุฎุด
345
00:31:39,680 --> 00:31:44,660
ุงู„ู…ุฑูŠุถ ููŠ chronic fatigue ุทุจุนุง ููŠ ู‡ุฐุง ุงู„ุญุงู„ุฉ ุฎุด
346
00:31:44,660 --> 00:31:50,580
ุนู„ู‰ ุฃู†ูŠู…ูŠุง ูˆุจุงู„ุชุงู„ูŠ ุจุฏุฃ ูŠุชุณูˆู‚ ุงู„ู…ุฑุถ chronic
347
00:31:50,580 --> 00:31:56,580
fatigue recurrent herb resistance infection ููŠor
348
00:31:56,580 --> 00:32:03,700
neutrophil dysfunction and easy browsing ู„ุฃู†ู‡ ููŠู‡
349
00:32:03,700 --> 00:32:08,840
thrombocytopenia ู‡ุฐู‡ ุงู„ุดุบู„ุงุช ูŠุนู†ูŠ ุตุงุฑ ููŠู‡ bone
350
00:32:08,840 --> 00:32:15,080
marrow failure ุทุจุนุง ู†ุชูŠุฌุฉ ุงู„ุงู†ูŠู…ูŠุง neutropenia ูˆ
351
00:32:15,080 --> 00:32:19,340
basal immunological dysfunction ูŠุนู†ูŠ ุชุดุชุบู„ุด ุงู„ู„ูŠ
352
00:32:19,340 --> 00:32:22,240
ุจูŠู‡ lymphocytes and thrombocytopenia
353
00:32:25,060 --> 00:32:31,060
ุงู„ู€ hepatomegaly ู…ุฑุงุช ุจูŠูƒูˆู† ู…ุตุงุญุจ ุงู„ู€ splenomegaly
354
00:32:31,060 --> 00:32:37,620
ูˆุงู„ chemical lymphocytes ู…ู…ูƒู† ุชุฎุฒูˆ ุฃุนุถุงุก ุงู„ุฌุณู… ุฃูˆ
355
00:32:37,620 --> 00:32:43,320
ุฃู…ุงูƒู† ููŠ ุงู„ุฌุณู… ุบุฑูŠุจุฉ ุฒูŠ ุงู„ scalp ุงู„ู„ูŠ ู‡ูˆ ุงู„ุตู„ุน ูˆ
356
00:32:43,320 --> 00:32:48,980
ุงู„ orbits ุงู„ูˆุฌู†ุชูŠู† subconjectiva ุชุญุช ุงู„ุนูŠู† gums
357
00:32:48,980 --> 00:32:53,800
pleural and lung parenchyma prostate and gonads
358
00:32:54,930 --> 00:33:04,870
ุฃู…ุงูƒู† ุบุฑูŠุจุฉ ุฌุฏุง ู…ู…ูƒู† ุชุตู„ ุฅู„ูŠู‡ุง ุงู„ู„ูŠ ู‡ูˆ ุงู„ ุงู„ ุงู„ ุงู„
359
00:33:04,870 --> 00:33:08,070
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
360
00:33:08,070 --> 00:33:08,230
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
361
00:33:08,230 --> 00:33:08,650
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
362
00:33:08,650 --> 00:33:11,710
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
363
00:33:11,710 --> 00:33:12,450
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
364
00:33:12,450 --> 00:33:12,550
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
365
00:33:12,550 --> 00:33:14,610
ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„ ุงู„
366
00:33:25,070 --> 00:33:29,370
ุจู†ุณู…ูˆู‡ุง browsing ุฎู„ู‘ูŠู†ูŠ
367
00:33:29,370 --> 00:33:33,190
ุฃู†ุง ุฃุณุฃู„ ุนู† ุงู„ investigation of the patient ูŠุนู†ูŠ
368
00:33:33,190 --> 00:33:36,550
ู„ูˆ ุจู†ุนู…ู„ CBC ุจูŠูƒูˆู† ุงู„ูˆู‚ุช blood cell ุนุงู„ูŠุฉ ุฏุงูŠู…ุง ููŠ
369
00:33:36,550 --> 00:33:40,770
ุงู„ chronic leukemia ุงู„ูˆู‚ุช blood cell ุนุงู„ูŠุฉ ุชุจู‚ู‰
370
00:33:40,770 --> 00:33:44,330
ุจู†ุนู…ู„ differential ูˆ ุจู†ุดูˆู ููŠู‡ lymphocytosis ูˆ
371
00:33:44,330 --> 00:33:47,610
ุจูŠูƒูˆู† ููŠู‡ absolute lymphocyte count ุจูŠูˆุตู„ ุนุฏุฏู‡ุง
372
00:33:47,610 --> 00:33:55,210
ู„ุฃูƒุชุฑ ู…ู† ุฎู…ุณูŠู† ุฃู„ู ูˆ ู…ู…ูƒู† ูŠุตู„ ู„ุชู„ุงุชู…ูŠุช ุฃู„ูุนู†ุฏ
373
00:33:55,210 --> 00:33:59,850
ุงู„ู…ุฑูŠุถ or even more ู…ุฑูŠุถ ุจูŠู‡ุงู†ูŠ ู…ู† ุฃู†ูŠู…ูŠุง
374
00:33:59,850 --> 00:34:05,650
ูˆุงู„ุฃู†ูŠู…ูŠุง ุจุชูƒูˆู† normochromic ูˆุงู„ู„ูŠ ู…ู…ูƒู† ุชุชุทูˆุฑ ููŠ
375
00:34:05,650 --> 00:34:13,130
ู…ุฑุงุญู„ ู‚ุงุฏู…ุฉ ู…ุน ุงู„ู…ุฑุถ ุซู… ุจูŠูƒูˆู† ููŠ autoimmune
376
00:34:13,130 --> 00:34:19,300
hemolysis ูŠุนู†ูŠ autoimmune hemolytic ุฃู†ูŠู…ูŠุงุงู„ู€
377
00:34:19,300 --> 00:34:22,860
Platelet ูˆ ู‡ุฐู‡ ู…ู† ู…ุถุงุนูุงุช ุงู„ู€ Autoimmune
378
00:34:22,860 --> 00:34:25,300
Hemorrhagic Anemia ู…ู† ู…ุถุงุนูุงุช ู‡ุฐุง ุงู„ู†ูˆุน ู…ู†
379
00:34:25,300 --> 00:34:31,940
ุงู„ู„ูˆูƒูŠู…ูŠุง Platelet ุจูŠูƒูˆู† ููˆุงุทูŠุฉ ุบุงู„ุจุง ุจูŠูƒูˆู† ููŠู‡
380
00:34:31,940 --> 00:34:36,420
Thrombocytopenic status ู„ูˆ ู‚ุจู„ู†ุง blood film ู‡ู†ู„ุงู‚ูŠ
381
00:34:36,420 --> 00:34:42,400
70 ู„ 99% ู…ู† ุงู„ูˆู‚ุช blood cell ู‡ูŠ mature lymphocytes
382
00:34:42,400 --> 00:34:48,440
ูˆ ู‡ู†ู„ุงุญุธููŠ ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง Smudge Cell ุงูˆ Smear Cell
383
00:34:48,440 --> 00:34:52,960
ุฎู„ุงูŠุง ู…ูุบุตุฉ are present ู„ูŠุดุŸ ู„ุฃู† ุงู„ู€ lymphocyte is
384
00:34:52,960 --> 00:34:58,240
in fragile cell ูˆุจุงู„ุชุงู„ูŠ ู„ู…ุง ุชูŠุฌูŠ ุชุนู…ู„ Smear ู…ุงุดูŠ
385
00:34:58,240 --> 00:35:04,000
ุนุฏุฏ ูƒุจูŠุฑ ู…ู† ุงู„ุฎู„ุงูŠุง ุณุชูƒูˆู† Smudged Immunopheno
386
00:35:04,000 --> 00:35:10,320
typically ุจู†ู„ุงุญุธ ุงู†ู‡ ููŠ ุจูŠ cell marker ุฒูŠ CD19
387
00:35:10,320 --> 00:35:16,880
positiveูˆ ุฃูŠุถุง ููŠ ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง Light Chain ุงู„ู„ูŠ ู‡ูˆ
388
00:35:16,880 --> 00:35:20,580
Light
389
00:35:20,580 --> 00:35:25,850
Chain ู…ูˆุฌูˆุฏุฉ ููŠ ุงู„ุฎู„ุงูŠุงุชุนุฑููŠู† ุงู†ู‡ Lighted Chain of
390
00:35:25,850 --> 00:35:28,550
Immunoglobulin ุงู†ุช ุนุงุฑููŠู† ุงู† ุงู„ B lymphocytes
391
00:35:28,550 --> 00:35:33,010
ุจุชุตู†ุน antibody ูˆ ุจุชุตู†ุน ุงู„ heavy chain ุซู… ุงู„
392
00:35:33,010 --> 00:35:35,830
lighted chain ุซู… ุจุชุฌู…ุนู‡ู… ู…ุน ุจุนุถ ูˆ ุชูƒูˆู† antibody
393
00:35:35,830 --> 00:35:40,730
ูููŠ ุงู„ุงุฎุฑ ุจูŠูƒูˆู† ูˆ ู‡ุฏูŠ ู…ุงุชุด ูˆุณู„ ููŠ ุงู„ุงุฎุฑ ุจูŠูƒูˆู† ููŠ
394
00:35:40,730 --> 00:35:46,310
lighted chain ูƒุชูŠุฑุฉ ู„ุณู‡ ู…ุง ุงุชุฌู…ุนุช ููŠ ุงู„ุฎู„ูŠุฉ ุงูŠุถุง
395
00:35:46,310 --> 00:35:50,430
ู…ู† ุงู„ immunophenotyping ุจูŠูƒูˆู† ููŠ CD5 positive ูˆ
396
00:35:50,430 --> 00:35:57,530
CD13 positiveูˆุฒุงุฏุฉ ููŠู„ู… ู„ .. ุงู„ู„ูŠ ู‡ูˆ chronic
397
00:35:57,530 --> 00:36:00,790
lymphocytic leukemia ูƒู„ู‡ุง ุงู†ูุณุงูŠุฏ ูˆู‡ูŠ ุงู„ู€ smudge
398
00:36:00,790 --> 00:36:05,730
cell ุงู„ู„ูŠ ุงุญู†ุง ุจู†ุญูƒูŠ ุนู„ูŠู‡ุง ู‡ูŠ .. ู‡ูŠ .. ู‡ูŠ .. ู‡ูŠุดูŠ
399
00:36:05,730 --> 00:36:12,350
.. ู‡ูŠ .. ู‡ูŠ ูˆุฑุง ุงู„ุฎู„ุงูŠุง .. ูู„ุต ุงู„ bone marrow
400
00:36:12,350 --> 00:36:15,650
aspiration ุจูŠูƒูˆู† ููŠ lymphocytic replacement of
401
00:36:15,650 --> 00:36:19,230
normal marrow ูˆู„ูˆ ุนู…ู„ู†ุง immunoglobulin
402
00:36:19,230 --> 00:36:21,750
electrophoresis ู‡ู†ู„ุงู‚ูŠ ู‚ู„ุฉ ููŠ ุงู„ normal
403
00:36:21,750 --> 00:36:28,250
immunoglobulinูˆ ุจูŠุชุทูˆุฑ ุงูˆ ุจูŠุฒุฏุงุฏ ูƒู„ ู…ุง ุงุฒุฏุงุฏ ุงู„ู…ุฑุถ
404
00:36:28,250 --> 00:36:34,090
ุณุงูŠุชูˆ ุฌูŠู†ุงุชูŠูƒู„ูŠ ู‡ูŠูƒูˆู† ุงุฑุจุน most important
405
00:36:34,090 --> 00:36:37,370
chromosome ุงู„ abnormality ููŠ ุงุฑุจุน chromosome
406
00:36:37,370 --> 00:36:46,860
deletion of 13Q14 ุนูŠุฒู… 12 ูˆ 11Q23ูˆุบุงู„ุจุง ูŠูƒูˆู†ูˆุง
407
00:36:46,860 --> 00:36:54,880
ู…ุตุญูˆุจูŠู† ุจ structure abnormality ู„ 17P ูˆู‡ุฐุง ุงู„ู…ูƒุงู†
408
00:36:54,880 --> 00:37:03,460
ุงู„ู„ูŠ ููŠ ุงู„ B53 ุฌูŠู† ู‡ูˆ tumor suppressor gene ุทูŠุจ
409
00:37:03,460 --> 00:37:11,120
ุงูŠุถุง ุงุณุชูƒู…ู„ุง ู„ู„ุชุดุฎูŠุต ูƒูŠู ู†ู‚ุฑุฑ ุงู„ clonality ุงูˆ ู†ุญุฏุฏ
410
00:37:11,120 --> 00:37:17,750
ุงู„ clonality of Bุงู„ู„ูŠ ุจุชู…ุซู„ 99% ู…ู† ุงู„ุญุงู„ุงุช or T
411
00:37:17,750 --> 00:37:23,050
ุงู„ู„ูŠ ุจุชู…ุซู„ 1% ู…ู† ุงู„ุญุงู„ุงุช ุฌุงู„ูˆ ููŠ ุงู„ B cell ุงู„
412
00:37:23,050 --> 00:37:30,190
Clonality ุจุชุคูƒุฏ ุจุงู„ุขุชูŠ ู…ุงุดูŠ ุจุฏุฃุช ุงู†ุง ุงู‚ูˆู„ ุงู† ูˆุงู„ู„ู‡
413
00:37:30,190 --> 00:37:34,570
ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ู…ูˆุฌูˆุฏุฉ ู‡ูŠ ุจุฑุนู†ุฉ B lymphocyte ูƒูŠุด
414
00:37:34,570 --> 00:37:38,960
ุจุชุนู…ู„ ุนุดุงู† ุงุคูƒุฏ ู‡ุฐุง ุงู„ุชุดุฎูŠุตุฃูˆู„ุง ู†ู…ุฑุฉ ูˆุงุญุฏ ุจุฏูŠ ุฃุฏูˆุฑ
415
00:37:38,960 --> 00:37:44,240
ุนู„ู‰ ุงู„ expression of either ูƒุนุจุฉ or ู„ู…ุฏุฉ lighted
416
00:37:44,240 --> 00:37:48,620
chain ู‡ุฐู‡ ุฃู†ูˆุงุน ุงู„ lighted chain of immunoglobulin
417
00:37:48,620 --> 00:37:55,680
ูˆูŠู† on cell surface membrane ู†ู…ุฑุฉ ุงุชู†ูŠู† ุทุจุนุง ู‡ุฐุง
418
00:37:55,680 --> 00:37:59,080
ุงู„ูƒู„ุงู… ู…ูˆุฌูˆุฏ ููŠ ุงู„ B-lymphocyte ู…ุด ู…ูˆุฌูˆุฏ ููŠ ุงู„ D
419
00:37:59,080 --> 00:38:02,420
-lymphocyte ู†ู…ุฑุฉ ุงุชู†ูŠู† presence of unique
420
00:38:02,420 --> 00:38:07,290
idiotypic specificityon the immunoglobulin
421
00:38:07,290 --> 00:38:10,630
produced by CLL cells ุงูŠุด ูŠุนู†ูŠ ุงูŠุฏูŠูˆุชูŠุจูŠูƒูŠ
422
00:38:10,630 --> 00:38:16,070
specificity ูŠุนู†ูŠ ุงู† ุงู„ุงู†ุชูŠุจุงุฏูŠ ูŠุชูƒูˆู† ู…ู† ุฌุฒุฆูŠู† ุฌุฒุก
423
00:38:16,070 --> 00:38:22,110
ุจูŠุณู…ูˆู‡ ุงู„ูุงุจ ูˆุฌุฒุก ุจูŠุณู…ูˆู‡ ุงู„ Fc ุงู„ูุงุจ ู‡ูˆ ู…ู†ุงุทู‚
424
00:38:22,110 --> 00:38:30,150
ุงุฑุชุจุงุท ุงู„ุงู†ุชูŠุจุงุฏูŠ ุจุงู„ุงู†ุชูŠุฌู† ูˆูƒู„ ุงู†ุชูŠุจุงุฏูŠ ู…ูˆุฌูˆุฏ ููŠ
425
00:38:30,150 --> 00:38:35,440
ุงู„ุฌุณู…B is specific only for one antigen ูˆุจุงู„ุชุงู„ูŠ
426
00:38:35,440 --> 00:38:39,740
ุงู„ูุฆุฉ ุงู„ุฑูŠุฌูŠู† ุจุชุฎุชู„ู between antibody ุจูŠุณู…ูˆุง ู‡ุฐู‡
427
00:38:39,740 --> 00:38:48,240
ุงู„ุงุฎุชู„ุงูุงุช Idiotypic specificity ูุงู†ุง ุจุฃูƒุฏู‡ุง ูˆ
428
00:38:48,240 --> 00:38:51,840
ุจุฏูˆุฑ ุนู„ูŠู‡ุง ูˆ ุจู„ุงู‚ูŠ ุงู† ุงู„ูŠู†ูˆุบู„ุงุจูŠู„ูŠู† are idiotypic
429
00:38:51,840 --> 00:38:54,200
in their specificity
430
00:38:57,020 --> 00:38:59,540
ุจุฑุถู‡ ุจูุญุต ุงู„ immunoglobulin gene rearrangement
431
00:38:59,540 --> 00:39:05,340
ู…ุงู‡ูŠ ุฃุตู„ุง ุฌูŠู†ุงุช ุชุชุตูุช ุนู† ุชูƒูˆูŠู† ุงู„ immunoglobulin
432
00:39:05,340 --> 00:39:09,980
ุฌูŠู†ุงุช ุงู„ immunoglobulin ุชุชุตูุช ููŠ ูƒู„ ู…ุฑุฉ ุชุตููŠุชู‡ุง
433
00:39:09,980 --> 00:39:13,380
ู…ุฎุชู„ูุฉ ูˆุจุงู„ุชุงู„ุช ุชุฏูŠู†ู‡ุง antibody ู…ุฎุชู„ู ููŠ ูƒู„ ู…ุฑุฉ
434
00:39:14,450 --> 00:39:22,290
ู†ู‚ุฑุฃ ุฃุฑุจุนุฉ typical B-cell CLL ุนู„ู‰ ุณุทุญ C-D19
435
00:39:22,290 --> 00:39:26,110
positive ูˆ C-D5 positive ูŠุจู‚ู‰ ุฏูˆู„ ุงู„ุฃุฑุจุน ุดุบู„ุงุช
436
00:39:26,110 --> 00:39:29,830
ุงู„ู„ูŠ ู…ู…ูƒู† ุฃู†ุง ุฃุคูƒุฏ ู…ู† ุฎู„ุงู„ู‡ู… ุงู„ chronality ุฃูˆ B
437
00:39:29,830 --> 00:39:37,210
-cell CLL ุนุดุฑ ุนู„ู‰ ุฎู…ุณุฉ ูˆ ุนุดุฑูŠู† ูู…ูŠุฉ ู…ู† ุงู„ู…ุฑุถู‰ of
438
00:39:37,210 --> 00:39:42,760
CLL ุจูŠุตูŠุฑ ุนู†ุฏู‡ู… autoimmune hemolytic anemiaูˆู„ูˆ
439
00:39:42,760 --> 00:39:47,820
ูุญุตู†ุง ุงู„ cost test ู‡ู†ู„ุงู‚ูŠ positive ูˆุงู„ุญุงุฌุฉ ุงู„ุชุงู†ูŠุฉ
440
00:39:47,820 --> 00:39:51,760
ุงู†ู‡ ุงู„ marrow aspiration ู„ู…ุง ุฃุณุญุจ bone marrow
441
00:39:51,760 --> 00:39:57,600
ู‡ู„ุงู‚ูŠ ููŠู‡ lymphoid plus ุงู„ุงูƒุชุฑ ู…ู† ุชู„ุงุชูŠู† ููŠ ุงู„ู…ูŠุฉ
442
00:39:57,600 --> 00:40:05,580
ู…ู† ุงู„ุฎู„ุงูŠุง ูŠุนุจุฑ ุนู† lymphoid ุงู„ classification ุฌุงู†ูŠ
443
00:40:05,580 --> 00:40:14,920
ุงู„ PCLุนู„ู‰ ุณุทุญ CD5 ุจูˆุฒูŠุชู ูˆ CD19 ูˆ 21 ูˆ 22 ุจูˆุฒูŠุชู ูˆ
444
00:40:14,920 --> 00:40:20,540
HLA-DR ุจูˆุฒูŠุชู HLA ู‡ูˆ ุนุจุงุฑุฉ ุนู† human leukocyte
445
00:40:20,540 --> 00:40:28,280
antigen ู…ู† ู†ูˆุน DR ู…ู† ู†ูˆุน DR ุงูŠุด ู‡ูˆ ู‡ุฐุง ู‡ุฐุง ุนุจุงุฑุฉ
446
00:40:28,280 --> 00:40:35,540
ุนู† ุงู„ู„ูŠ ู‡ูˆ human ุนุจุงุฑุฉ ุนู† MHC gene MHC gene
447
00:40:35,540 --> 00:40:35,960
product
448
00:40:39,330 --> 00:40:43,670
ุทุจุนุงู‹ ุงู„ู€ Antigen Density ุนู„ู‰ ุงู„ู€ BCL ู‡ูˆ ุฃุณู„ูˆูƒ
449
00:40:43,670 --> 00:40:47,130
ุฃูƒุชุฑ ู…ู† ุงู„ุงู†ูุณุงูŠุช ุงู„ุทุจูŠุนูŠ ุฌุฏุงู‹ ูƒู„ู…ุง ุชุญูˆู„ุช ุงู„ุฎู„ูŠุฉ
450
00:40:47,130 --> 00:40:53,910
ุฅู„ู‰ ู„ูˆูƒูŠู…ูƒุณู„ ูƒู„ู…ุง ูู‚ุฏุช ู…ุงุดูŠ ุฌุฒุก ูƒุจูŠุฑ ู…ู† ุงู„ู„ูŠ ู‡ูˆ
451
00:40:53,910 --> 00:40:57,070
ุงู„ู€ Antigen Density ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€ cell surface
452
00:40:57,070 --> 00:41:03,450
molecule ุงู„ู„ูŠ ุนู„ู‰ ุณุทุญู‡ุง ูˆู‡ุฐู‡ ุฃุญุฏ ุงู„ุทุฑู‚ ุงู„ุชูŠ ูŠุนู†ูŠ
453
00:41:03,450 --> 00:41:07,530
ุชุชู‡ุฑุจ ุงู„ ู„ูˆูƒูŠู…ูƒุณู„ ู…ู† ุงู„ immune response
454
00:41:09,820 --> 00:41:15,260
ู†ู‚ุทุฉ ุชุงู„ุชุฉ ุงู„ู€ CLL ุณู„ ุนู„ู‰ ุณุทุญู‡ุง CD25 ูˆุฏู‡ ุนุจุงุฑุฉ ุนู†
455
00:41:15,260 --> 00:41:22,660
IL-2 ุฑูŠุณุจุชูˆุฑ ู…ุงุดูŠ it will express it weakly ุงุญู†ุง
456
00:41:22,660 --> 00:41:26,760
ู‚ู„ู†ุง ู‡ุฐู‡ ุงู„ุฎู„ูŠุฉ ุชุชุญุฑุฑ ู…ู† ุงู„ control mechanism ูˆู…ู†
457
00:41:26,760 --> 00:41:29,780
ูŠุชุญูƒู… ุจุงู„ B-lymphocyte ุบุงู„ุจุง T-lymphocytes
458
00:41:29,780 --> 00:41:34,440
ูˆุจุงู„ุชุงู„ูŠ ู…ู† ุฎู„ุงู„ ุงู„ receptor ู‡ุฐุง ูˆุจุงู„ุชุงู„ูŠ ู„ู…ุง ุจูŠู‚ู„
459
00:41:34,440 --> 00:41:38,080
ุงู„ receptor ู‡ุฐุง ุจุชู‚ุทุน ุงู„ T-lymphocyte ุชุฃุซุฑ ููŠ ุงู„ B
460
00:41:39,920 --> 00:41:47,440
CD5 ู‡ูˆ ุนุจุงุฑุฉ ุนู† Pan T Cell Marker ู…ูˆุฌูˆุฏ ุนู„ู‰ ูƒู„ ุงู„ู€
461
00:41:47,440 --> 00:41:51,980
T-Lymphocytes ูˆู…ู„ุนุจูˆู†
462
00:41:51,980 --> 00:41:57,260
ูƒุจูŠุฑ ููŠ ุงู„ู€ T Cell Activation ูˆู…ู† ู‡ุฐุง ุงู„ู…ู†ุทู„ู‚
463
00:41:57,260 --> 00:42:01,080
ูˆุฌูˆุฏู‡ ุนู„ู‰ ุงู„ู€ T-Lymphocytes ู‚ุงู„ูˆุง ุฅู†ู‡ ู…ู† ู‡ุฐุง
464
00:42:01,080 --> 00:42:06,700
ุงู„ู…ู†ุทู„ู‚ ุจูŠุตูŠุฑ ููŠู‡ Autoimmune Disease as a
465
00:42:06,700 --> 00:42:08,860
complication of BCLL
466
00:42:11,060 --> 00:42:17,280
ูˆู‡ุฐุง ุงู„ููŠุฌุฑุฑ ุจูŠุจูŠู† ู„ูŠ ุงู„ pathophysiology of CLL
467
00:42:17,280 --> 00:42:24,240
ู…ุงุดูŠ ู‡ุฐุง ู‡ูˆ ุจูŠุชู…ูŠุฒ ุจุงู„ู‡ุงุชู ูƒู†ุง ุชุนุฑูŠู ุงู„ CLL ุจูŠุตูŠุฑ
468
00:42:24,240 --> 00:42:27,960
accumulation ููŠู‡ุง of long lived and poorly
469
00:42:27,960 --> 00:42:32,240
functioning lymphocyte ู‡ุฐุง ู‡ูŠ ู„ู…ุง ุจูŠุตูŠุฑ ู‡ุฐุง ุงู„ูƒู„ุงู…
470
00:42:32,930 --> 00:42:36,470
ูŠุนู†ูŠ ุงู„ู„ูŠ ู‡ูˆ ู‡ุฐุง ุจูŠุถุฑุจ ููŠ ุฃุฑุจุน ุงุชุฌุงู‡ุงุช ู…ุฎุชู„ูุฉ
471
00:42:36,470 --> 00:42:41,810
ุงู„ุฃูˆู„ุงู†ูŠ ู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุจุชุชุฎุฐ ุงู„ lymph nodes ูุจุตูŠุฑ
472
00:42:41,810 --> 00:42:46,290
infiltration ู„ู„ lymph nodes ูˆู‚ูˆู„ู†ุง ู‡ุฐู‡ ุงูˆู„ ูŠุนู†ูŠ
473
00:42:46,290 --> 00:42:49,370
diagnostic tool ู…ู…ูƒู† ู†ุณุชุฎุฏู…ู‡ุง ุงู†ู‡ ู†ุชุญุณุณ ุงู„ lymph
474
00:42:49,370 --> 00:42:54,070
nodes ุจุงู„ุงุฌู‡ูŠุฉ ุงู„ุงุฑุด ูˆุจูŠุตูŠุฑ ููŠู‡ massive adenopathy
475
00:42:54,070 --> 00:43:01,080
ู…ุงุดูŠ ุงู„ู…ุฑุฉ ุงุชู†ูŠู†ุงู„ู„ูŠ ุฏุงูŠู…ู‹ุง ุจูŠุจู‚ู‰ ุฏูŠู†ูˆุจุงุซูŠ ุงูˆ ุงู„
476
00:43:01,080 --> 00:43:03,820
lymph node ุงู„ู„ูŠ ุนุงุฑู ู…ู†ูƒ is associated with
477
00:43:03,820 --> 00:43:08,640
splenomegaly ูˆูŠูˆู… ูŠูƒูˆู† ููŠู‡ splenomegaly ุจูŠูƒุจุฑ ุงู„
478
00:43:08,640 --> 00:43:13,380
splen ู…ุงุดูŠ ุจูŠุตูŠุฑ ุธุงู‡ุฑุฉ ุจูŠุณู…ูˆู‡ุง hypersplenism ุงูŠุด
479
00:43:13,380 --> 00:43:17,260
ุจูŠุตูŠุฑ ููŠ ุงู„ hypersplenismุŸูƒุงู†ูˆุง ุจูŠุฎุฒู† ูƒู…ูŠุงุช ูƒุจูŠุฑุฉ
480
00:43:17,260 --> 00:43:21,520
ู…ู† ุงู„ุฎู„ุงูŠุง ู„ุฅู† ูˆุงุญุฏ ูˆุธุงุฆู ุงู„ู€Spleen ู‡ูˆ ุงู„ุชุฎุฒูŠู†
481
00:43:21,520 --> 00:43:25,800
ูƒู…ุงู† ุจุงู„ุฅุถุงูุฉ ู„ูŠู‡ ุงู„ู„ูŠ ู‡ูˆ ุงู„ุนู…ู„ ุงู„ู…ู†ุงุนูŠ ุฃูˆ ุงู„ูˆุธูŠูุฉ
482
00:43:25,800 --> 00:43:30,220
ุงู„ู…ู†ุงุนูŠุฉ ู„ู‡ุŒ ุงู„ู„ูŠ ุฎู…ุณุŒ ุณุช ูˆุธุงุฆู ู…ุฎุชู„ูุฉ ุทุจ ู„ู…ุง
483
00:43:30,220 --> 00:43:33,440
ุจูŠุตูŠุฑ ููŠู‡ุง hypersplenismุŒ ุดูˆ ูŠุนู†ูŠุŸ ุฎุฒู† ุฎู„ุงูŠุง ุฒูŠุฏู‡ุง
484
00:43:33,440 --> 00:43:36,360
ู„ุฌูˆู‡ุŒ ูู‚ู„ ุนุฏุฏู‡ุง ููŠ ุงู„ peripheral blood ูุตุงุฑ ููŠ
485
00:43:36,360 --> 00:43:42,630
ุฃู†ู‡ูŠู†ูŠุงุŒ ุซู… ุจูˆุณูŠุทูˆุจูŠู†ูŠุงุŒ ุฃู†ูŠูˆุชุฑูˆุจูŠู„ูŠูˆู…ุงุดูŠ ูˆ ุทุจุนุง
486
00:43:42,630 --> 00:43:46,490
ู‡ุฐู‡ ุงุฐุง ุตุงุฑุช ุจูŠุตูŠุฑ ููŠู‡ุง hemorrhage ูˆ ุงุฐุง ุตุงุฑ ููŠู‡ุง
487
00:43:46,490 --> 00:43:49,610
hemorrhage ุจูŠุชู‚ู„ ุงู„ุฎู„ุงูŠุง ุงูƒุชุฑ ูˆ ุงูƒุชุฑ ูุจุงู„ุชุงู„ูŠ
488
00:43:49,610 --> 00:43:59,030
ุจุชุฒูŠุฏ .. ุจุชุฒูŠุฏ ุณูˆุก ู‡ุฐู‡ ุงู„ู…ุธุงู‡ุฑ ุงู„ุงุชุฌุงู‡
489
00:43:59,030 --> 00:44:03,810
ุงู„ุชุงู„ุช ุงู„ู„ูŠ ุจูŠุถุฑุจ ููŠ ุงู„ู…ุฑุถ ู‡ุฐุง ุงู†ู‡ ุจูŠุตูŠุฑ ููŠู‡
490
00:44:03,810 --> 00:44:08,890
bomber ูˆ replacement of the normal cell by
491
00:44:08,890 --> 00:44:13,570
abnormal cellูˆุทุจุนุงู‹ ูŠุนู†ูŠ ุจูŠุตูŠุฑ ููŠู‡ bomber ูˆ
492
00:44:13,570 --> 00:44:16,990
failure ูŠุนู†ูŠ ุงู†ู‡ูŠ ู…ู† thrombocytopenia ุงู†ูŠูˆุชุฑูˆุจูŠู†ูŠุง
493
00:44:16,990 --> 00:44:23,290
ูˆุจุฑุถู‡ ุงุฐุง ุตุงุฑุช ู‡ุฒูŠุฑ ููŠู‡ hemorrhage ูˆุฒูŠุฏ ู‚ู„ุฉ ู‡ุฐู‡
494
00:44:23,290 --> 00:44:29,530
ุงู„ุฎู„ุงูŠุง ูุจุฒูŠุฏ ุงู„ู…ุธุงู‡ุฑ ุณูˆุงุก ุงู„ุฐู†ุจ ุงู„ุฑุงุจุน ุงู„ู„ูŠ ุจุชุฏุฑุฏ
495
00:44:29,530 --> 00:44:34,150
ููŠู‡ ุงู„ู„ูŠ ู‡ูˆ ุจุฏุฑุฏ ููŠ ู‡ุฐุง ุงู„ู…ุฑุถ ูƒู†ุง ุจูŠุตูŠุฑ ููŠู‡
496
00:44:34,150 --> 00:44:37,900
autoimmune disease ูƒูŠูุŸุจูŠุตูŠุฑ ููŠู‡ impairment ู„ู„
497
00:44:37,900 --> 00:44:40,860
immunological activity ุจูŠุจุทู„ ุนู†ุฏู‡ ู…ู†ุงุนุฉ ู„ู„ู…ุฑูŠุถ
498
00:44:40,860 --> 00:44:45,360
ูˆุจูŠุจุทู„ ุนู†ุฏู‡ ู…ู†ุงุนุฉ ู„ุฃู†ู‡ ุจุชู‚ู„ ุงู„ immunoglobulin
499
00:44:45,360 --> 00:44:49,820
ุงู„ุทุจูŠุนูŠุฉ ุจูŠุตูŠุฑ ููŠู‡ hypogamaglobulinemia ูˆู„ุฃู†
500
00:44:49,820 --> 00:44:52,720
ุงู„ุฎู„ุงูŠุง ุงู„ู„ูŠ ุชุญูˆู„ุช ุฅู„ู‰ cancer cell ูŠุนู†ูŠ non
501
00:44:52,720 --> 00:44:58,430
functioning cell ูุจูŠุตูŠุฑ ุงู„ู…ุฑูŠุถ ุนู†ุฏู‡ infectionูˆุจุตูŠุฑ
502
00:44:58,430 --> 00:45:02,430
ุนู†ุฏู‡ Autoimmune Phenomena ูˆู‚ู„ู†ุง ู…ู…ูƒู† ูŠูƒูˆู† Antibody
503
00:45:02,430 --> 00:45:06,250
against his RBC's ูุจุตูŠุฑ ููŠู‡ Autoimmune Hemolytic
504
00:45:06,250 --> 00:45:12,750
Anemia ุงูˆ Antibody against his Blatelet ุจุตูŠุฑ ููŠู‡
505
00:45:12,750 --> 00:45:16,990
ุญุฏ ุจูŠุณู…ูˆู‡ุง Idiopathic Thrombocytopenic Pairup ุงูˆ
506
00:45:16,990 --> 00:45:22,470
Antibody ุถุฏ ุงู„ู†ูŠุชุฑูˆููŠู„ ุชุจุนุชู‡ ูˆุจุตูŠุฑ ููŠู‡ Immune
507
00:45:22,470 --> 00:45:24,390
Neutropenia
508
00:45:26,590 --> 00:45:31,410
ูˆู‡ูŠ ุงู„ู…ุฑุงุญู„ ุงู„ู…ุฑุถูŠุฉ ู„ู‡ุฐุง ุงู„ู…ุฑุถ ู‚ุงู„ูˆุง ุงู„ู€ staging
509
00:45:31,410 --> 00:45:34,490
is very important for the prognosis and treatment
510
00:45:34,490 --> 00:45:39,690
ุจู‡ู… ุฌุฏุง ูŠุนุฑููˆุง ููŠ ุฃูŠ ู…ุฑุญู„ุฉ ู…ู† ุงู„ู…ุฑุงุญู„ ู„ุฃูŠ ู…ุฑุญู„ุฉ
511
00:45:39,690 --> 00:45:46,610
ูˆุตู„ ู„ู„ู…ุฑูŠุถ ุนู†ุฏ ุงู„ุชุดุฎูŠุต ููŠ ู‡ุฐุง ุงู„ู…ุฑุถ ูˆุจุงู„ุชุงู„ูŠ
512
00:45:46,610 --> 00:45:50,090
ุงุนุชู…ุฏูˆุง two staging system ูˆุงุญุฏ ุงุณู…ู‡ Rhea ูˆุงู„ุชุงู†ูŠ
513
00:45:50,090 --> 00:45:57,450
ุงุณู…ู‡ pilotูˆุงู„ู…ุฑุถ ูŠู…ุฑ ููŠ ุฎู…ุณ ู…ุฑุงุญู„ ู…ุฎุชู„ูุฉ ู…ุฑุญู„ุฉ
514
00:45:57,450 --> 00:46:02,310
Zero ูู‚ุท ุงู„ู…ุฑูŠุถ ุจูŠุฌูŠ ู†ุงุจู„ lymphocytosis ุจูŠูƒูˆู† ุฃูƒุชุฑ
515
00:46:02,310 --> 00:46:11,690
ู…ู† 150 ุฃู„ู ู†ู…ุฑุฉ ูˆุงุญุฏ ุจูŠูƒูˆู† ุจูŠุฌูŠ ุงู„ู…ุฑูŠุถ ุจ Stage
516
00:46:11,690 --> 00:46:16,990
Zero ูŠุนู†ูŠ lymphocytosis ูˆููŠ lymph node enlargement
517
00:46:16,990 --> 00:46:22,430
ุจูŠูƒูˆู† ููŠ ู…ุฑุญู„ุฉ ูˆุงุญุฏ ู…ุฑุญู„ุฉ Stage TwoูŠูƒูˆู† ู‡ู†ุงูƒ
518
00:46:22,430 --> 00:46:30,730
lymphocytosis ูˆ liver or endisplane ุจุงู„ุงุถุงูุฉ
519
00:46:30,730 --> 00:46:37,830
ู„ู„ุฃุฏูŠู†ูˆุจุงุชูŠ lymph node enlargement Stage
520
00:46:37,830 --> 00:46:44,350
3 ูŠูƒูˆู† ู‡ู†ุงูƒ lymphocytosis ูˆ ุฃู†ูŠู…ูŠุง ุฃูˆุฑุฌุงู†ูˆู…ูŠุฌุง
521
00:46:44,350 --> 00:46:49,170
ู„ุฃูˆุฑ ุฃุฏูŠู†ูˆุจุงุชูŠ Stage 4 ูŠูƒูˆู† ู‡ู†ุงูƒ Stage Zero
522
00:46:49,170 --> 00:46:54,810
lymphocytosis ูŠุนู†ูŠู…ุน Thrombocytopenia ุจุงู„ุฅุถุงูุฉ ู„ู„ู€
523
00:46:54,810 --> 00:46:59,110
Organomegaly ูˆRadenopathy ูŠุจู‚ู‰ ุฎู…ุณ ู…ุฑุงุญู„ ู…ุฎุชู„ูุฉ
524
00:46:59,110 --> 00:47:06,850
ุญูƒุงู‡ุง ุงู„ู…ุฌู…ูˆุนุฉ RIA ููŠ ุจุงู†ูŠุฉ Classification ู‚ุงู„ูˆุง
525
00:47:06,850 --> 00:47:10,230
ุงู„ู…ุฑุถ ุจุฏู†ุง ู†ุนู…ู„ู‡ Classification ู„ุชู„ุช ู…ุฑุงุญู„ ู…ุด ุฎู…ุณ
526
00:47:10,230 --> 00:47:16,430
ู…ุฑุงุญู„ Stage A ูˆB ูˆC ููŠ A ูˆู…ุนุธู… ุงู„ู…ุฑุถู‰ ุจูŠุชุดุฎุตูˆุง ููŠ
527
00:47:16,430 --> 00:47:21,530
ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ ุฎู…ุณูŠู† ู„ุณุชูŠู† ูุงู„ู…ูŠุฉ ู…ู† ุงู„ู…ุฑุถู‰ุจูŠุชุดุฎุตูˆุง
528
00:47:21,530 --> 00:47:26,990
ููŠ ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ ุจูŠูƒูˆู† ุนู†ุฏู‡ organomegaly ู…ุงุดูŠ ููŠ
529
00:47:26,990 --> 00:47:32,190
stage zero ุงูˆ ูˆุงุญุฏ ุงูˆ ุงุชู†ูŠู† ู…ู†ุทู‚ุฉ ูˆุงุญุฏ ุณูุฑ ุงูˆ ูˆุงุญุฏ
530
00:47:32,190 --> 00:47:35,130
ุงูˆ ุงุชู†ูŠู† ุงูŠุด ูŠุนู†ูŠ ุณูุฑ ูŠุนู†ูŠ lymphocytosis ุงูŠุด ูŠุนู†ูŠ
531
00:47:35,130 --> 00:47:38,910
ูˆุงุญุฏ ูŠุนู†ูŠ adenopathy ุงูˆ ุงุชู†ูŠู† liver or spleen
532
00:47:38,910 --> 00:47:44,290
ูˆุงู„ู‡ูŠู…ูˆุฌู„ุจูŠู† ูˆุงู„ platelets ู„ุณุงุช ู…ุง ุงุชุฃุซุฑูˆุด ุจูŠู‡
533
00:47:44,290 --> 00:47:47,070
ุชู„ุงุชูŠู† ููŠ ุงู„ู…ูŠุฉ ู…ู† ุงู„ู…ุฑุถู‰ ุจูŠุฌูˆุง ููŠ ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ
534
00:47:47,530 --> 00:47:51,370
ุจุชุดุฎุตูˆุง ููŠ ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ ูˆุจูŠูƒูˆู† ุนู†ุฏู‡ ุชู„ุงุชุฉ ุงูˆ ุงุฑุจุนุฉ
535
00:47:51,370 --> 00:48:00,730
ุงูˆ ุฎู…ุณ ู…ู†ุงุทู‚ ู…ุตุงุจุฉ ู…ุงุดูŠ ูˆ ุจุจุฏุฃ ู„ุณู‡ ุงู„ anemia ูˆ ุงู„
536
00:48:00,730 --> 00:48:04,470
cytopenia ูˆ ุงู„ thrombocytopenia ู…ุง ุงุชุฃุซุฑูˆุด
537
00:48:04,470 --> 00:48:09,150
ูุงู„ู‡ู…ุบู„ูˆุจูŠู† ุงูƒุชุฑ ู…ู† ุนุดุฑุฉ ูˆ ุงู„ platelet ุงูƒุชุฑ ู…ู†
538
00:48:09,150 --> 00:48:14,550
ู…ุงุฆุฉ ุงู„ู ูˆ stress ูŠ ุงู‚ู„ ู…ู† ุนุดุฑูŠู† ูู…ูŠุฉ ู…ู† ุงู„ุญุงู„ุงุช
539
00:48:14,550 --> 00:48:19,560
ุจุชุดุฎุตูˆุง ููŠ ู‡ุฐู‡ ุงู„ุญุงู„ุฉุจุบุถ ุงู„ู†ุธุฑ ุนู† ู…ู†ุงุทู‚ ุงู„ุฅุตุงุจุฉ
540
00:48:19,560 --> 00:48:26,600
ุจูŠูƒูˆู† ุงู„ hemoglobin ุจุฏุฃ ูŠุชุฃุซุฑ ุตุงุฑ ุนู†ุฏู‡ anemia ูˆ
541
00:48:26,600 --> 00:48:30,580
ุตุงุฑ ุนู†ุฏู‡ thrombocytopenia ุงู„ platelet ุฃู‚ู„ ู…ู† 100
542
00:48:30,580 --> 00:48:39,500
ุฃู„ู treatment ูŠุนู†ูŠ ุงู„ treatment ู…ุงููŠ ุดูุงู‚ุฉ ููŠ ู‡ุฐุง
543
00:48:39,500 --> 00:48:48,920
ุงู„ู…ุฑุถ ูˆ the only hopeูู‚ุท ุงู„ symptom control ุงุญู†ุง
544
00:48:48,920 --> 00:48:54,640
ุจู†ุชุญูƒู… ุจู†ุฎูู ุงู„ symptoms ุนู†ุฏ ุงู„ู…ุฑูŠุถ ุทูŠุจ ุงู„
545
00:48:54,640 --> 00:48:58,880
indication for treatment ู‚ุงู„ูˆุง ู†ู…ุฑุง ูˆุงุญุฏ ุงุฐุง ูƒุงู†
546
00:48:58,880 --> 00:49:02,980
ุจุฏู‰ ูŠุนุงู†ู‰ ูˆู‚ุชุด ูŠุนู†ูŠ ู„ุงุฒู… ุงู†ุง ุงุจุฏุฃ ุนู„ุงุฌ ู†ู…ุฑุง ูˆุงุญุฏ
547
00:49:02,980 --> 00:49:07,160
ุงุฐุง ูƒุงู† ููŠ trouble sub organomegaly ููŠ ุนุถูˆ ู…ู†
548
00:49:07,160 --> 00:49:12,930
ุงู„ุฃุนุถุงุก ุงู„ู…ุตุนุจุฉุจุฏุฃ ูŠุฒุนุฌูˆุง ู†ู…ุฑุฉ ุงุชู†ูŠู† ููŠ hemolytic
549
00:49:12,930 --> 00:49:17,910
episodes ูŠุนู†ูŠ ููŠ autoimmune hemolytic anemia ู†ู…ุฑุฉ
550
00:49:17,910 --> 00:49:22,950
ุชู„ุงุชุฉ ุจุนู…ู„ bone marrow suppression ุนุดุงู† ุงุฎูู ู…ู†
551
00:49:22,950 --> 00:49:30,630
ุฒูŠุงุฏุฉ ุงูˆ ุฒูŠุงุฏุฉ ุงู„ู…ู‡ูˆู„ุฉ ููŠ ุงู„ white blood cell ุงู„
552
00:49:30,630 --> 00:49:34,090
modality of treatment ุงู†ุง ู…ุด ุฑุงุญ ุงุฏุจุฌ ูƒุชูŠุฑ ุนู„ู‰
553
00:49:34,090 --> 00:49:39,750
ุงู„ุนู„ุงุฌุงุช ุงู„ู„ูŠ ุจูŠุงุฎุฏูˆู‡ุงุจุณ ุฎู„ู‘ูŠู†ุง ู†ุฐูƒุฑู‡ู… ูุจูŠุนุชูˆุง
554
00:49:39,750 --> 00:49:46,090
chemotherapy ุชูุตูŠู„ุงุชู‡ ู…ุด ู…ุทู„ูˆุจุฉ ู…ู†ูƒ ุงูˆ ู…ู†ูƒ ุจูŠุนู…ู„ูˆุง
555
00:49:46,090 --> 00:49:51,150
radiotherapy ู„ู„ุนุถูˆ ุงู„ู…ุตุงุจ ุนุดุงู† ูŠุฎูููˆุง ู…ู† ุญุฌู…ู‡ ุณูˆุงุก
556
00:49:51,150 --> 00:49:55,510
ูƒุงู† lymph nodes ุงูˆ spleen ุงูˆ liver ุจูŠุนู…ู„ูˆุง .. ุจุฏูˆุง
557
00:49:55,510 --> 00:50:02,190
monoclonal antibody ูŠุนู†ูŠ antibody against ุงู„ู„ูŠ ู‡ูˆ
558
00:50:05,690 --> 00:50:10,830
different types ู…ุงุดูŠ ู…ู† ุงู„ุฒูŠุงุฏุงุช ูุจูŠุนุชูˆุง Anti-CD
559
00:50:10,830 --> 00:50:21,770
52 ูˆุจูŠุนุชูˆุง Retoximab ุงูˆ Anti-CD 20 ูˆู‡ุฐุง ุจูŠู‚ู„ู„ ู…ู†
560
00:50:21,770 --> 00:50:28,930
ุงูŠุด ู…ู† ุงู„ effect of evolved
561
00:50:28,930 --> 00:50:31,810
ุงู„ู„ูŠ ู‡ูˆ cells or
562
00:50:34,560 --> 00:50:41,560
ุจุนุฏ ู…ุฑุงุช ุจูŠูƒูˆู† ููŠู‡ antibody abnormal antibody
563
00:50:41,560 --> 00:50:46,920
ุจูŠุนู…ู„ูˆุง splenectomy ุจูŠุดูŠู„ูˆุง ุงู„ spleen ู„ุฅู†ู‡ ุจูŠูƒูˆู†
564
00:50:46,920 --> 00:50:53,600
ููŠู‡ painful and bulky spleen ุนู†ุฏ ุงู„ู…ุฑูŠุถ ูˆูŠุจุนุชูˆุง
565
00:50:53,600 --> 00:50:56,840
immunoglobulin replacement ูŠุนู†ูŠ ุจูŠุฒูˆุฏูˆุง ุงู„ู…ุฑูŠุถ ุจ
566
00:50:56,840 --> 00:50:59,800
immunoglobulin ู„ุฅู†ู‡ ู…ุงุนู†ุฏู‡ immunoglobulin ูƒู„
567
00:50:59,800 --> 00:51:05,120
ุงู„ุฎู„ุงูŠุง ุบูŠุฑ ุทุจูŠุนูŠุฉ ูˆู„ุง ุชุณุชุทูŠุนุชูƒูˆู† normal
568
00:51:05,120 --> 00:51:10,120
immunoglobulin ุทุจุนุง ุงู„ stem cell transplant ู‡ุฐุง
569
00:51:10,120 --> 00:51:13,700
under clinical trial ููŠ ุงู„ุบุงู„ุจ ุจูŠุนู…ู„ู‡ูˆุด ู„ู„ู…ุฑุถู‰ ู„ุฃู†
570
00:51:13,700 --> 00:51:17,020
ุงู„ู…ุฑูŠุถ ุจูŠูƒูˆู† ู‚ูˆู„ู†ุง ู‡ุฐุง ุงู„ู…ุฑุถ ุจูŠุตูŠุจ ู„ุงุฎุชูŠุงุฑูŠุฉ
571
00:51:17,020 --> 00:51:21,380
ูˆุจุงู„ุชุงู„ูŠ ุงู„ู…ุฑูŠุถ ู„ู† ูŠุณุชุทูŠุน ุงู† ูŠุชุญู…ู„ stem cell
572
00:51:21,380 --> 00:51:26,800
transplantation ุจุฑู‚ู…ูˆุฒุฒ 50% ู…ู† ุงู„ุญุงู„ุงุช will
573
00:51:26,800 --> 00:51:31,940
receive partial remission ูˆูŠุนู†ูŠ ุจูŠุฎุด ููŠ ุดูุงุก ุฌุฒุฆูŠ
574
00:51:32,580 --> 00:51:39,880
ุฃู‚ู„ ู…ู† 30% ู…ู† ุงู„ุญุงู„ุงุช ุณุชุญุตู„ ุนู„ู‰ ุชู…ูŠูŠู„ ุชู…ุงู… ูˆ 30%
575
00:51:39,880 --> 00:51:43,920
ู…ู† ุงู„ุญุงู„ุงุช ุณุชุญุตู„ ุนู„ู‰ ุชุฏุฎู„ ู„ู€ Pro-Lymphocytic
576
00:51:43,920 --> 00:51:48,640
Leukemia 5% ู…ู† ุงู„ุญุงู„ุงุช ุณุชุฏุฎู„ูˆุง ููŠ ุณู†ุฏุฑูˆู… ูŠุณู…ูˆู†ู‡
577
00:51:48,640 --> 00:51:53,460
ุฑูŠุฎุชุฑ ุณู†ุฏุฑูˆู… ูˆู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุนู†ุฏู…ุง ุชุฏุฎู„ ุฅู„ู‰ ู…ูƒุงู†
578
00:51:53,460 --> 00:51:59,820
ุงู„ู„ูŠู…ู ู†ูˆุฏ ูˆุชุนุดุด ููŠ ุงู„ู„ูŠู…ู ู†ูˆุฏ ูŠุณู…ูˆู† ู‡ุฐู‡ ุฏุงุฆุฑุฉ
579
00:51:59,820 --> 00:52:05,370
ุฑูŠุฎุชุฑ ุณู†ุฏุฑูˆู…ุจู‡ูŠูƒ ุจู†ูƒูˆู† ุฎู„ุตู†ุง ุงู„ chronic myeloid
580
00:52:05,370 --> 00:52:09,150
leukemia ูˆ chronic lymphocytic leukemia ูˆ ู†ุงุฎุฏ ู„ู†ุง
581
00:52:09,150 --> 00:52:13,090
ู…ุซุงู„ ุงูˆ ู…ุซุงู„ูŠู† ุนู„ู‰ ุงู„ pro lymphocytic leukemia ู…ู†
582
00:52:13,090 --> 00:52:15,710
ุงู„ุงุณู… pro lymphocytic leukemia ู‡ุฐุง ุนุจุงุฑุฉ ุนู† ุงู„
583
00:52:15,710 --> 00:52:18,630
chronic types of leukemia ุทุจุนุง ุงู„ pro lymphocytic
584
00:52:18,630 --> 00:52:21,970
leukemia ูŠุนู†ูŠ ุงู„ู„ูŠ pro lymphocyte ู‡ูŠ ุงู„ู…ุตุงุจุฉ ุงู„
585
00:52:21,970 --> 00:52:26,450
pro lymphocyte ูŠุนู†ูŠ ุงู„ู„ูŠ ููŠ ุงู„ maturationmyelocyte
586
00:52:26,450 --> 00:52:30,410
ูˆู‚ู„ู†ุง ู‡ุฐู‡ ุงู„ู…ุฑุญู„ุฉ ู‡ูŠ ู…ุฑุญู„ุฉ ุงูƒุจุฑ ู…ู† ุงู„ myeloblast
587
00:52:30,410 --> 00:52:35,190
ูˆุจุงู„ุชุงู„ูŠ severity of disease ู‡ูŠูƒูˆู† ุงูƒุชุฑ ู…ุงุดูŠ it's
588
00:52:35,190 --> 00:52:39,650
the second most common ุจูŠู…ุซู„ ุญูˆุงู„ูŠ ุนุดุฑุฉ ูู…ูŠุฉ ู…ู† ุงู„
589
00:52:39,650 --> 00:52:45,110
B cell ุงู„ุงุฌู†ุงู†ุณูŠ ูˆ ุงู„ incidence ููŠ ุงู„ู…ูŠู„ ุงูƒุชุฑ ู…ู†
590
00:52:45,110 --> 00:52:50,510
ุงู„ููŠู…ูŠู„ ุงู„ T type T problem ููŠ ุณู†ุฉ ุงู„ูƒู„ูŠูƒูŠู…ูŠุง ุจุดูƒู„
591
00:52:50,510 --> 00:52:56,040
ุญูˆุงู„ูŠ ุฑุจุน ุงู„ุญุงู„ุฉุงู„ู€ Leukomagenesis ุทุจุนุง ููŠ ู†ูุณ
592
00:52:56,040 --> 00:52:59,700
ุงู„ูƒุฑู…ุฒูˆู…ุฉ ุงู„ู€ abnormality ุงู„ู„ู‰ ุชูˆุง ุญุงูƒูŠู† ุนู„ูŠู‡ุง 11
593
00:52:59,700 --> 00:53:06,720
ูˆ 14 ูˆ 13 ู…ุงุดูŠ ุญุงู„ูŠ 50 ู„ 75% ู…ู† ุงู„ translocation
594
00:53:06,720 --> 00:53:13,400
ุจุชูˆุตูŠุจ ุงู„ BCL1 Oncogenู…ุดูŠ ูˆุงุญุฏุฉ ู‡ูˆ ู…ูƒุงู† ุชูƒูˆูŠู† ุงู„
595
00:53:13,400 --> 00:53:19,480
heavy chain gene ุงู„ู„ูŠ ู…ุณุคูˆู„ ุนู† ุงู„ heavy chain
596
00:53:19,480 --> 00:53:24,560
immunoglobulin product
597
00:53:24,560 --> 00:53:32,280
ูƒู…ุงู† ููŠ ุงู„ุฃูˆ ูƒุฑู…ุฒูˆู… 14Q332 ู‡ุฐู‡ ุจุฑุถู‡ ู…ู†ุทู‚ุฉ ุจูŠุตูŠุฑ
598
00:53:32,280 --> 00:53:37,540
ููŠู‡ุง expression ู„ ุจูŠู‡ lymphocyte growth factor ู„ู…ุง
599
00:53:37,540 --> 00:53:41,200
ุจุชู†ุถุฑุจ ูŠุนู†ูŠ ุจูŠุจุทู„ ููŠู‡ ุจูŠู‡ lymphocyte growth factor
600
00:53:41,200 --> 00:53:45,520
ููŠ other cytogenetic abnormality ุฒูŠ ู…ุง ู‚ู„ุช ู„ูƒูˆุง ููŠ
601
00:53:45,520 --> 00:53:52,880
Trisomy 12 ููŠ ุงู„ู„ูŠ ู‡ูˆ rearrangement of 3B 11B and
602
00:53:52,880 --> 00:54:01,140
12B ุจุงู„ู…ู‚ุงุฑู†ุฉู…ุงุจูŠู† ุงู„ู€ TBLL ูˆ ุงู„ู€ PBLL TBLL ูƒุฑู…ุฒูˆู…
603
00:54:01,140 --> 00:54:09,100
ุงู„ุฃุจู†ุฑู…ุงู„ุชูŠ ุจู†ุดูˆูู‡ุง ููŠ ุงู„ู€ 14Q1111 ููŠ ู…ู†ุทู‚ุฉ ู…ุณุฆูˆู„ุฉ
604
00:54:09,100 --> 00:54:15,040
ุนู† ุงู„ู€ T cell receptor Alpha chain geneูˆ ู‡ุฐู‡ ุงู„ู€
605
00:54:15,040 --> 00:54:18,100
Abnormality ุทุจุนุงู‹ ู‡ูŠ ู‡ุฐู‡ ุงู„ frequency of ุฃูƒุชุฑ ู…ู†
606
00:54:18,100 --> 00:54:23,260
ุฎู…ุณูŠู† ูู…ูŠุฉ ู…ู† ุญุงู„ูŠุงุช ุงู„ TBLL
607
00:54:23,260 --> 00:54:28,620
recognition ูˆุฌูˆุฏ ุฃูƒุชุฑ ู…ู† ุฎู…ุณ ูˆ ุฎู…ุณูŠู† ูู…ูŠุฉ ูู…ู‡ Pro
608
00:54:28,620 --> 00:54:32,560
lymphocytes ููŠ ุงู„ peripheral blood at presentation
609
00:54:33,440 --> 00:54:36,880
ูˆ ุทุจุนุง ู‡ุฐู‡ ุฎู„ูŠุฉ ุนุจุงุฑุฉ ุนู† ุฎู„ูŠุฉ ุฃูƒุจุฑ larger than
610
00:54:36,880 --> 00:54:42,200
lymphocytes ูˆ abundance of cytoplasm ูˆ ุจูŠูƒูˆู† ููŠู‡ุง
611
00:54:42,200 --> 00:54:46,900
condensed chromatin material prominent nucleolus ูˆ
612
00:54:46,900 --> 00:54:54,960
ู‡ุฐุง ู‡ูŠ ุดูƒู„ ุงู„ pro lymphocytic leukemia ุทุจุนุง ุงู„ pro
613
00:54:54,960 --> 00:54:59,720
lymphocytic leukemia ุจุชุชู…ูŠุฒ
614
00:54:59,720 --> 00:55:04,560
ุจูˆุฌูˆุฏ raised white blood cellุจูˆุตู„ ู„ู„ุนุฏุฏ ุงู„ุงู‚ู„ ู…ู†
615
00:55:04,560 --> 00:55:12,660
ู…ุงุฆุฉ ุงู„ู ู„ูƒู† ู…ู…ูƒู† ูŠุตู„ ู„ุนุดุฑ ู…ู„ูŠูˆู† ู…ุงุดูŠ ูˆุจุงู„ุชุงู„ูŠ
616
00:55:12,660 --> 00:55:20,320
ุทุจุนุง ู…ุนุธู…ู‡ุง Pro lymphocytes ุงู„ TBLL ุจุชูƒูˆู† ู…ุดู‡ูˆุฑุฉ
617
00:55:20,320 --> 00:55:25,620
ุจุฒูŠุงุฏุฉ white blood cell ุงูƒุชุฑ ู…ู† BLLู…ุนุธู… ุงู„ุญุงู„ุงุช
618
00:55:25,620 --> 00:55:29,800
ุนู†ุฏู‡ู… Trombocytopenia and anemia secondary to P
619
00:55:29,800 --> 00:55:33,440
bone marrow infiltration sphenomegaly where bone
620
00:55:33,440 --> 00:55:38,480
marrow is characteristics it's
621
00:55:38,480 --> 00:55:42,160
not needed ููŠ ุงู„ุบุงู„ุจ ู„ุง ู†ุญุชุงุฌู‡ for diagnosis ุฅู„ุง
622
00:55:42,160 --> 00:55:48,310
ุนุดุงู† ุฃูุฑู‚ ุจูŠู† ุงู„ P ูˆ ุงู„ุจู„ุงู„ ูˆ Tblal ุฌุงู„ูˆุง ููŠ ุงู„ B
623
00:55:48,310 --> 00:55:53,610
ุจู„ุงู„
624
00:55:53,610 --> 00:55:57,430
ุงู„ุฎู„ูŠุฉ ุจุชูƒูˆู† large ูˆ pale blue ูˆ not granular
625
00:55:57,430 --> 00:56:01,450
cytoplasm ูˆ ูŠูƒูˆู† ููŠ single nucleus ูˆ single
626
00:56:01,450 --> 00:56:07,380
nucleusุจูŠู†ู…ุง ุงู„ู€ TPLL ุจุชูƒูˆู† slightly smaller ูˆููŠู‡
627
00:56:07,380 --> 00:56:11,800
regular nucleus ูˆุบุงู„ุจุง ุจูŠูƒูˆู† clifted and slightly
628
00:56:11,800 --> 00:56:15,020
more mesophilic cytoplasm with a zoophilic
629
00:56:15,020 --> 00:56:19,320
granules ูˆู‡ุฐู‡ ูุฑูˆู‚ุงุช ู…ุง ุจูŠู† ุงู„ amino phenotyping
630
00:56:19,320 --> 00:56:24,800
of P, PLL ูˆTPLL ุฒูŠ ู…ุง ุงู†ุชูˆุง ุดุงูŠููŠู† ุงู„ P ู…ุฎุฏ
631
00:56:24,800 --> 00:56:29,360
ุงู„ุฃุฑู‚ุงู… ุงู„ุนุงู„ูŠุฉ ูˆT ู…ุฎุฏ ุงู„ุฃุฑู‚ุงู… ุงู„ูˆุงุทูŠุฉุงู„ู€
632
00:56:29,360 --> 00:56:35,100
Pathophysiology ุฒูŠุงุฏุฉ ุงู„ู€ lymphocyte count ุจุฒูŠุงุฏุฉ
633
00:56:35,100 --> 00:56:37,060
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ
634
00:56:37,060 --> 00:56:38,400
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ
635
00:56:38,400 --> 00:56:41,260
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ
636
00:56:41,260 --> 00:56:43,640
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ
637
00:56:43,640 --> 00:56:48,380
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ
638
00:56:48,380 --> 00:56:54,590
ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจูŠุฑ ุจุดูƒู„ ูƒุจู„ุฃู† ู‡ุฐุง ุงู„ู…ุฑุถ
639
00:56:54,590 --> 00:56:59,730
ุฃุณูˆุก ูˆุฃูƒุซุฑ ู…ุถุงุฏู‹ุง ู„ุฃู† ุงู„ู€ lymph node ู„ูŠุณ ู…ุฑู‡ู‚ุฉ ูˆู„ุง
640
00:56:59,730 --> 00:57:01,670
ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง
641
00:57:01,670 --> 00:57:02,750
ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง
642
00:57:02,750 --> 00:57:03,630
ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง
643
00:57:03,630 --> 00:57:04,470
ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง
644
00:57:04,470 --> 00:57:06,310
ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง
645
00:57:06,310 --> 00:57:08,830
ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง
646
00:57:08,830 --> 00:57:11,170
ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง
647
00:57:11,170 --> 00:57:18,610
ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง ูˆู„ุง ู†ุดูˆูู‡ุง
648
00:57:19,120 --> 00:57:25,840
ุงู„ู€ white blood cell ุจูŠู‚ู„ู„ ู…ู† ุงู„ mass bulk ูˆ ุงู„
649
00:57:25,840 --> 00:57:31,720
remission ุบุงู„ุจุง is only short term ูŠุนู†ูŠ ูุชุฑุงุช
650
00:57:31,720 --> 00:57:36,480
ู‚ุตูŠุฑุฉ ู…ู…ูƒู† ุงู„ู…ุฑูŠุถ ูŠุฎุด ููŠู‡ุง ููŠ ุงู„ remission ู‡ูŠุฑูŠ
651
00:57:36,480 --> 00:57:42,500
ุณู„ูˆ ูƒูŠู…ูŠุง ู…ู† ุงู„ุฅุณู… ู‡ูŠุฑูŠ ูŠุนู†ูŠ ุดุนุฑ ุณู„ูˆ ูƒูŠู…ูŠุง ุจุชูƒูˆู†
652
00:57:42,500 --> 00:57:49,390
ุฎู„ูŠุฉู…ูˆุฌูˆุฏ ููŠ ุงู„ู€ cell membrane ุชุจุนู‡ุง ุงู„ู„ูŠ ู‡ูˆ ุงู„ู€
653
00:57:49,390 --> 00:57:55,280
Hairy-like structureุงู„ู…ุฑุถ ุจูŠุตูŠุจ ุงู„ุงุฎุชูŠุงุฑูŠุฉ ูˆ ุงู„
654
00:57:55,280 --> 00:57:58,840
patient present with marked splenomygaly ู„ูƒู† ู…ุงููŠ
655
00:57:58,840 --> 00:58:02,040
lymphadenopathy ูˆ ุงู„ patient have fatigue and
656
00:58:02,040 --> 00:58:05,340
malaise ู„ุฅู†ู‡ ููŠู‡ ุฃู†ูŠู…ูŠุง ููŠู‡ pancytopenia ุงู„
657
00:58:05,340 --> 00:58:09,380
preference meal ุจูŠูƒูˆู† ููŠู‡ mononuclear lymphocytoid
658
00:58:09,380 --> 00:58:14,080
cell with hairy projection on their surface ู…ู†
659
00:58:14,080 --> 00:58:19,040
ุฃุณูˆุฃ ุงู„ุฃู…ุฑุงุถ ุจุงู„ู…ู†ุงุณุจุฉ ู„ุจูˆู… ู…ุฑูˆ ูŠูŠู„ุฏ ุฅุฏุฑุงูŠ ุชุจุชุฏูŠ
660
00:58:19,040 --> 00:58:21,600
ุชุณุญุจ ุจูˆู† ู…ุฑูˆ ูˆ ู‡ุฐู‡ ู…ู† ุงู„ุตูุงุช characteristic
661
00:58:21,600 --> 00:58:26,190
featureุจู†ุชูŠุฌุฉ ุชุณุญุจ ุจูˆู† ู…ุงุฑูˆ Aspiration ุชุทู„ุน
662
00:58:26,190 --> 00:58:30,230
ุงู„ุฃู†ุจูˆุจุฉ ูุงุถูŠุฉ ุฃูˆ sorry ุงู„ุณูŠุฑู†ุฌ ูุงุถูŠ ู†ุชูŠุฌุฉ ุฅูŠุด
663
00:58:30,230 --> 00:58:34,670
ู†ุชูŠุฌุฉ ุงู„ fibrosis ุงู„ู„ูŠ ุตุงุฑ ููŠ ุงู„ ุจูˆู† ู…ุงุฑูˆ ูˆุจุงู„ุชุงู„ูŠ
664
00:58:34,670 --> 00:58:38,680
ุจูŠุณู…ูˆู‡ุง dry tap phenomenonSplenectomy and
665
00:58:38,680 --> 00:58:43,980
Interferon ู‡ูˆ ูƒู…ูˆ ุซูŠุฑุงุจูŠูˆุชูƒ ุฏุฑุงุฌุณ ูŠุนู†ูŠ ู…ุงุนู…ู„ู‡
666
00:58:43,980 --> 00:58:47,660
successful is not ูŠุนู†ูŠ successful ู„ูƒู† it's not
667
00:58:47,660 --> 00:58:53,780
long lasting ู…ุงุดูŠ ู‡ุงูŠ ุงู„ู„ูŠ ู‡ูŠ ุฑุณุงู„ุฉ ูˆุงู„ุฅูŠู…ูŠู† ูˆููŠู†ูˆ
668
00:58:53,780 --> 00:58:59,680
ุชุงูŠุจู†ุฌ ุชุจุนู‡ุง ูŠุจู‚ู‰ ุจูŠุณู„ ุชุงูŠุจ ู‡ูŠ ูƒูˆู„ุฉ ุณูŠุฏูŠู‡ุงุช ุนุงู„ูŠุฉ
669
00:59:00,440 --> 00:59:05,740
ูˆุงู„ูƒุฑู…ุฒูˆู…ุฉ ุงู„ุงุฏู†ุงุฑู…ุงู„ูŠุชูŠ ู…ุงููŠุด CD5 ู„ูƒู† ููŠู‡ CD11C
670
00:59:05,740 --> 00:59:13,820
CD25 IL-2 ุฑูŠุณุจุชูˆุฑ ูƒู„ู‡ู… ู…ูˆุฌูˆุฏูŠู† cytochemistry ู‡ุฐู‡
671
00:59:13,820 --> 00:59:17,460
ู†ู‚ุทุฉ ู…ู‡ู…ุฉ ุจุงู„ู…ู†ุงุณุจุฉ ุจูŠูƒูˆู† ุนู†ุฏู‡ ุญุงุฌุฉ ุจูŠุณู…ูˆู‡ุง trap
672
00:59:17,460 --> 00:59:21,920
positive ูˆ trap ุงุฎุชุตุงุฑ ุงู„ุชุงุฑุชุฑูŠุช resistant acid
673
00:59:21,920 --> 00:59:26,400
phosphataseู…ุงุดูŠ ุงูŠุด ูŠุนู†ูŠุŸ ููŠ ุญูˆุงู„ูŠ ุฎู…ุณุฉ different
674
00:59:26,400 --> 00:59:31,260
acid phosphatase ููŠ ุงู„ุฌุณู… ู†ุฌูŠ ุจู†ุนู…ู„ ู†ุณุจุฎ ุจุงู„ acid
675
00:59:31,260 --> 00:59:35,720
phosphatase stain ุนุงุฏุฉ
676
00:59:35,720 --> 00:59:40,800
it blocks positive ูˆู„ู…ู‘ุง ู†ุถูŠู ุงู„ tartarate to
677
00:59:40,800 --> 00:59:45,520
remove the stain ููŠ ู‡ุฐุง ุงู„ู…ุฑุถ ุจุชุถู„ ุงู„ stain will
678
00:59:45,520 --> 00:59:52,980
be resist ู‡ุชุถู„ ูˆุนุดุงู† ู‡ูŠูƒ ุจูŠุณู…ูˆู‡ุงTrap Positive ููŠู‡
679
00:59:52,980 --> 00:59:56,500
Resistance ู„ู„ุณุชุฑูŠู† PathophysiologyุŒ fatigue ูˆ easy
680
00:59:56,500 --> 01:00:01,260
bruising ูˆ repeat infection ุนุงุฏุฉ it's more common
681
01:00:01,260 --> 01:00:07,560
than CLL ููŠู‡ Large Spleen which is not minimal ูˆ
682
01:00:07,560 --> 01:00:13,120
ุงู„ุฑูู†ูˆุฏ is rare TreatmentุŒ ุจู†ุดูŠู„ ุงู„ spleen ู…ุฑูŠุญ
683
01:00:13,120 --> 01:00:21,330
ุงู„ู…ุฑูŠุถุŒ ู‡ุฐูŠ ุฃูˆู„ ุฎุทูˆุฉ ูˆ ุฎุตูˆุตุง ููŠ Stage 1 ูˆ 2ูˆุงู„
684
01:00:21,330 --> 01:00:24,670
treatment ุจุชุนุชู…ุฏ ุนู„ู‰ ุงู„ู„ูŠ ู‡ูˆ reaction of spleen
685
01:00:24,670 --> 01:00:29,130
removal ู„ูˆ 40% ู…ู† ุงู„ู…ุฑุถู‰ require chemotherapy
686
01:00:29,130 --> 01:00:34,490
after splenectomy with long with and it will be
687
01:00:34,490 --> 01:00:41,890
long term to maintain partial remission ุจูŠุนุชู‚ูˆุง
688
01:00:41,890 --> 01:00:44,690
alpha interferon available
689
01:00:51,110 --> 01:00:57,090
ุงู„ู…ุดูƒู„ุฉ ุงู† ู‡ู†ุงูƒ ุงู†ุชุจุงุฏ ู„ุฃู„ูุง ุงู†ุชุฑููŠุฑูˆู… ูˆุจุงู„ุชุงู„ูŠ
690
01:00:57,090 --> 01:00:59,130
ุงุณุชุนู…ุงู„ุชู‡ ู…ุญุฏูˆุฏุฉ
691
01:01:01,000 --> 01:01:07,260
ุจู‡ูŠูƒ ุจู†ูƒูˆู† ุฎู„ุตู†ุง ุงู„ู…ุญุงุถุฑุฉ ูˆู…ุฑู‘ูŠู†ุง ุนู„ู‰ different
692
01:01:07,260 --> 01:01:11,480
types of chronic leukemia ุจู…ุง ููŠู‡ุง ุงู„ myeloid ูˆ
693
01:01:11,480 --> 01:01:19,340
ุฃูƒุงู… ู…ู† ู†ูˆุน ู…ู† ุงู„ lymphoid ูˆ ุดูƒุฑุง